Unspecific neurodegenerative disorder

G6_NEURODEGENERATIVE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00, G30 Hospital discharge:* ICD-9 — 3310 Hospital discharge: ICD-8 — 29010 Cause of death: ICD-10 — F00, G30 Cause of death:* ICD-9 — 3310 Cause of death: ICD-8 — 29010 KELA reimbursements: KELA codes — 307 KELA reimbursements: ICD-10 — F00, G30 Medicine purchases:* ATC — N06D 4 out of 7 registries used, show all original rules.	24991
4. Check minimum number of events Min. number of events 3	24991
5. Include endpoints F5_ALZHDEMENT	24991
6. Filter based on genotype QC (FinnGen only)	24306

Control definitions (FinnGen only)

Control exclude: G6_ALZHEIMER

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	G6_NEURODEGENERATIVE
CONTROL_EXCLUDE	G6_ALZHEIMER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_ALZHDEMENT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G30\|F00
HD_ICD_9	3310
HD_ICD_8	29010
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G30\|F00
COD_ICD_9	3310
COD_ICD_8	29010
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	307
KELA_REIMB_ICD	G30\|F00\|3110
KELA_ATC_NEEDOTHER
KELA_ATC	N06D
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Unspecific neurodegenerative disorder based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	24306	11647	12659
Unadjusted period prevalence (%)	5.00	4.13	5.80
Median age at first event (years)	79.45	79.69	79.22

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20514: Matched controls
140168

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

6.0

319.9

674

790

N06AX11

ATC

mirtazapine; oral

1.8

313.8

6836

30005

N05AX08

ATC

risperidone; systemic

10.3

307.7

5075

4351

F009, G309,

ICD-10 Finland

+∞

307.7

382

WYA20

NOMESCO Finland

Home visit

7.4

307.7

901

865

F03

ICD-10 Finland

Unspecified dementia

8.7

307.7

3517

3268

SPAT1216

SPAT

Assessment of functional ability

2.8

307.7

5814

17420

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

307.7

8353

35062

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

11.9

307.7

440

258

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

307.7

5849

22688

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

157.9

307.7

2848

143

R53

ICD-10 Finland

Malaise and fatigue

2.3

307.7

6161

22416

F0019, G301,

ICD-10 Finland

+∞

307.7

631

P20

ICPC

Memory disturbance

11.2

307.7

10858

12809

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

290.2

307.7

4485

135

TAB00

NOMESCO Finland

Lumbar puncture

4.4

307.7

1090

1749

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

307.7

5030

16623

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.6

307.7

3719

8163

SPAT1053

SPAT

Memory test

4.8

307.7

8437

17945

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1441.9

307.7

5200

R41.0

ICD-10 Finland

Disorientation, unspecified

4.1

307.7

1403

2480

G30.0

ICD-10 Finland

Alzheimer disease with early onset

1306.0

307.7

1128

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

307.7

2811

6150

SPAT1234

SPAT

Support of social functional capacity

4.0

307.7

2288

4217

G30

ICD-10 Finland

Alzheimer disease

289.7

307.7

1273

G30.8

ICD-10 Finland

Other Alzheimer disease

351.7

307.7

2916

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

307.7

4509

16199

N06DA04

ATC

galantamine; oral

244.2

307.7

3149

104

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

847.4

307.7

4763

SPAT1254

SPAT

Administration of medicine

2.4

307.7

4501

14836

N06DA02

ATC

donepezil; oral

320.0

307.7

9310

363

N05BA04

ATC

oxazepam; oral

2.1

307.7

5936

23025

N06AX26

ATC

vortioxetine; oral

3.7

307.7

1228

2356

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

7.5

307.7

5986

7312

N06DX01

ATC

memantine; oral

523.3

307.7

11817

363

A28

ICPC

Limited function/disability NOS

3.1

307.7

7282

21121

R41.3

ICD-10 Finland

Other amnesia

5.8

307.7

1539

1927

P70

ICPC

Dementia

34.2

307.7

2387

537

AXX01, ,

SPAT

3.9

307.7

1258

2300

G30.1

ICD-10 Finland

Alzheimer disease with late onset

459.7

307.7

9548

265

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.5

307.7

1644

3378

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

391.2

307.7

557

N05AH04

ATC

quetiapine; oral

4.2

307.7

4540

8887

F05.1

ICD-10 Finland

Delirium superimposed on dementia

17.4

307.7

527

212

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

482.0

307.7

813

F06.7

ICD-10 Finland

Mild cognitive disorder

6.6

307.7

1862

2074

AA1AD

NOMESCO Finland

CT of head and brain

2.0

307.7

7525

32047

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

908.3

307.7

1365

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

16.7

307.7

375

156

SPAT1245

SPAT

Provision of support and information to patient’s family members

5.1

307.7

2373

3530

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

1636.8

307.7

715

L28

ICPC

Limited function/disability (L)

2.1

307.7

5434

20571

N06DA03

ATC

rivastigmine; oral, transdermal

258.5

307.7

6338

242

G20

ICD-10 Finland

Parkinson disease

3.3

302.5

1325

2847

SPAT1304

SPAT

Counselling and guidance related to ageing

2.3

300.7

2762

8814

A04

ICPC

Weakness/tiredness general

2.1

293.5

3679

13319

N03AG01

ATC

valproic acid; systemic, rectal

3.3

293.0

1277

2734

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

8.1

278.2

453

390

SPAT1101

SPAT

Orthostatic test

2.8

270.8

1623

4195

U04

ICPC

Incontinence urine

2.7

268.6

1759

4764

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.3

267.5

1176

2529

F00

ICD-10 Finland

Dementia in Alzheimer disease

27.8

257.8

233

SPAT1301

SPAT

No procedures

1.7

252.4

7279

34154

N87

ICPC

Parkinsonism

4.8

251.5

667

977

XA800

NOMESCO Finland

Neuropsychological investigation

4.0

251.1

841

1493

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.6

250.6

1662

4525

I95.1

ICD-10 Finland

Orthostatic hypotension

2.8

245.8

1454

3725

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

226.0

3152

11759

N05AH03

ATC

olanzapine; systemic

3.2

225.9

1025

2245

N06AB10

ATC

escitalopram; oral

2.0

214.9

2824

10299

SPAT1229

SPAT

Assessment of need for aid

2.1

209.4

2322

7937

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

204.1

1485

4221

S72.0

ICD-10 Finland

Fracture of neck of femur

2.5

201.3

1490

4270

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

200.4

6900

33399

A06AD11

ATC

lactulose; oral

1.7

196.1

4305

18472

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.2

195.6

613

1032

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

512.8

193.7

223

S01.0

ICD-10 Finland

Open wound of scalp

2.2

193.7

1994

6606

SPAT1360

SPAT

Extensive global examination

2.2

193.4

1872

6046

SPAT1252

SPAT

Overall medication plan or its review

2.2

193.4

1972

6508

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.0

189.8

2464

8917

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.4

188.8

544

855

N02BE01

ATC

paracetamol; systemic, rectal

1.8

186.3

17461

106467

A29

ICPC

General symptom/complaint other

1.9

177.4

2965

11675

N02AA05

ATC

oxycodone; systemic

1.7

176.5

4604

20632

F0009, G300,

ICD-10 Finland

+∞

175.6

196

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.9

174.8

977

2416

R55

ICD-10 Finland

Syncope and collapse

1.8

174.2

2997

11903

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

1299.1

172.4

195

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

6.3

171.5

340

372

N05AD01

ATC

haloperidol; systemic

2.9

165.0

909

2229

F05.9

ICD-10 Finland

Delirium, unspecified

3.2

162.2

749

1654

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

161.5

3494

14829

S06.0

ICD-10 Finland

Concussion

2.0

157.3

2166

7972

SPAT1172

SPAT

Guidance concerning hydration

2.9

156.9

851

2068

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

156.2

3902

17211

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

8.2

153.5

247

209

Z75.5

ICD-10 Finland

Holiday relief care

4.9

151.2

391

559

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4.6

149.3

406

607

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

147.9

1295

3992

F21, ,

ICPC

5.0

144.7

362

502

F01.9

ICD-10 Finland

Vascular dementia, unspecified

3.2

141.9

640

1392

AXX01

NOMESCO Finland

Memory assessment

19.8

140.3

141

130

Kela drug reimbursment

Malignant tumour

0.3

139.5

532

10247

F001, G301,

ICD-10 Finland

1089.9

136.6

155

R42

ICD-10 Finland

Dizziness and giddiness

1.5

135.4

5305

25945

F0029, G308,

ICD-10 Finland

+∞

130.7

146

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

347.9

130.5

152

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

130.1

3581

16103

SPAT1139

SPAT

Nutrition survey

2.6

129.8

843

2254

W19

ICD-10 Finland

Unspecified fall

1.8

129.2

2138

8333

OAB76

NOMESCO Finland

General guidance on nutrition and food

42.0

126.5

104

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

125.0

2182

8641

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

124.5

1527

5373

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

37.2

122.3

103

F0014, G301,

ICD-10 Finland

+∞

121.7

136

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

121.3

4046

38510

G31.0

ICD-10 Finland

Circumscribed brain atrophy

7.2

121.0

215

207

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

119.2

2308

9419

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

15.4

118.7

132

N04BD01

ATC

selegiline; oral

3.4

118.7

483

982

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

467.0

117.9

136

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

115.4

6037

31124

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

114.6

1443

5122

H02AB02

ATC

dexamethasone; systemic

0.4

113.8

636

10368

SPAT1167

SPAT

Insertion of urinary catheter

2.3

113.4

1011

3133

F01.2

ICD-10 Finland

Subcortical vascular dementia

5.8

109.4

236

283

SPAT1263

SPAT

Sampling

1.4

106.7

7881

43107

SPAT1050

SPAT

Extensive neurological examination

2.9

106.4

554

1313

Z29

ICPC

Social problem NOS

3.3

105.2

445

928

S70.0

ICD-10 Finland

Contusion of hip

2.2

105.2

983

3106

N27

ICPC

Fear of neurological disease other

3.2

105.1

475

1034

C10AA01

ATC

simvastatin; oral

1.4

102.3

10667

61649

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

98.9

2010

8293

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

97.4

3180

14784

W0A10

NOMESCO Finland

Mapping of psychosocial situation

15.1

96.5

108

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

95.2

1777

7151

G04BD12

ATC

mirabegron; oral

1.6

94.1

2862

13079

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

23.5

93.9

R1250

NOMESCO Finland

Evaluation of functional capability

3.1

93.2

440

984

G04CB01

ATC

finasteride; oral

1.5

92.5

3357

15956

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

7.1

91.8

164

159

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

91.7

1409

5339

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.5

90.2

350

689

N30.0

ICD-10 Finland

Acute cystitis

1.5

89.7

3119

14678

N06AB06

ATC

sertraline; oral

1.8

88.8

1420

5446

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

88.2

1490

16846

ICB01, ,

SPAT

8.2

86.8

138

115

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

86.4

6108

32847

G04CA02

ATC

tamsulosin; oral

1.4

85.1

6271

33933

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

225.3

83.5

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

83.3

649

1892

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

83.0

1992

8573

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

82.8

2132

21792

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.5

82.6

563

1540

N04BD02

ATC

rasagiline; oral

4.2

82.4

250

410

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

82.0

1425

5603

E86

ICD-10 Finland

Volume depletion

2.3

80.2

688

2093

N06AB04

ATC

citalopram; systemic

1.5

79.6

3554

17561

N28

ICPC

Limited function/disability (N)

2.9

78.8

423

1020

F00, F03,

ICD-10 Finland

+∞

78.7

N29

ICPC

Neurological sympt/complt other

2.8

78.5

453

1137

AA1CG, ,

SPAT

4.8

77.7

200

285

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

23.1

77.6

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

75.0

1453

5894

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

204.7

74.7

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

72.9

655

2032

193

Kela drug reimbursment

Rasagiline

4.6

72.3

198

298

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.2

71.9

680

2156

R1250, ,

SPAT

2.9

71.2

383

925

SPAT1251

SPAT

Organisation of medication

2.0

71.1

839

2899

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

70.7

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

70.7

1710

7360

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.3

67.5

588

1801

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

66.8

817

2858

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

65.9

5683

31226

A27

ICPC

Fear of other disease NOS

1.9

65.9

982

3675

R5110, ,

SPAT

1.7

65.3

1433

6009

R44.1

ICD-10 Finland

Visual hallucinations

4.6

64.1

175

263

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

63.4

1406

5910

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.4

62.6

482

1397

A04AA02

ATC

granisetron; systemic, transdermal

0.4

62.4

274

5011

N17

ICPC

Vertigo/dizziness

1.5

62.3

2520

12157

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

62.1

1691

7482

IHZ08, ,

SPAT

9.5

62.0

WX402

NOMESCO Finland

General anaesthesia

0.6

61.3

1547

16007

F0011, G301,

ICD-10 Finland

479.3

60.8

F01

ICD-10 Finland

Vascular dementia

5.1

60.7

148

201

N05AD03

ATC

melperone; systemic

2.8

60.4

342

850

R33

ICD-10 Finland

Retention of urine

1.5

60.0

2105

9859

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

472.4

59.9

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

59.9

1059

4177

J01CA08

ATC

pivmecillinam; oral

1.3

59.7

6334

35722

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.2

59.4

525

1618

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.1

59.1

594

1930

N07AA05, ,

ATC

+∞

59.0

P05

ICPC

Senility, feeling/behaving old

4.1

58.7

185

313

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.8

58.7

328

809

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

58.6

142

3511

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.9

58.6

872

3261

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

58.4

919

3498

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

57.8

2781

13848

SPAT1262

SPAT

Handing over of treatment supplies

1.4

57.8

3553

18463

N04BC04

ATC

ropinirole; oral

3.0

56.8

278

636

AA1AD, ,

SPAT

6.7

56.5

105

107

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

56.5

141

3429

SPAT1014

SPAT

Treatment of eyes

2.4

55.0

431

1260

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

54.6

2542

12572

WZC30

NOMESCO Finland

Teaching

0.6

53.7

1404

14452

H02AA02

ATC

fludrocortisone; oral

3.2

51.5

229

494

F002, G308,

ICD-10 Finland

210.3

51.4

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

51.3

1630

7459

J01EA01

ATC

trimethoprim; systemic

1.3

50.6

4905

27197

Z28

ICPC

Limited function/disability (Z)

4.2

50.6

153

251

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

50.4

5428

30520

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

5.5

48.8

109

136

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

48.4

834

3262

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

48.3

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

48.3

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

48.1

5738

32639

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

47.6

472

1525

J01DB01

ATC

cefalexin; oral

1.3

47.5

14426

91312

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

376.0

47.5

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

47.3

1946

9385

F05.8

ICD-10 Finland

Other delirium

3.1

46.9

213

466

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

46.9

480

1571

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

46.7

2948

15326

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

369.1

46.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

46.5

2626

13407

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

53.1

45.9

N04BX02

ATC

entacapone; oral

4.2

45.7

139

229

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

45.7

475

1564

F009, F03,

ICD-10 Finland

+∞

45.6

A04AA01

ATC

ondansetron; systemic, rectal

0.5

45.5

504

6504

SPAT1125

SPAT

Stoma care and guidance

2.2

45.2

442

1421

P29

ICPC

Psychological sympt/compl other

2.0

44.8

527

1817

N02AJ06

ATC

codeine and paracetamol; systemic

0.8

44.8

4523

37425

A10AB05

ATC

insulin aspart; parenteral

1.5

44.6

1353

6123

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

44.5

909

3731

Z2445

NOMESCO Finland

Psychologist

2.3

44.3

354

1045

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

4.8

43.8

113

162

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

43.6

159

3178

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

43.4

2810

14653

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

8.9

43.4

XF606, ,

SPAT

3.6

43.1

158

300

G04BD08

ATC

solifenacin; oral

1.5

42.7

1450

6723

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

26.7

42.6

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.3

42.4

353

1061

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

42.3

2098

19230

SPAT1260

SPAT

Consultation of another employee

1.3

42.2

3222

17217

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

41.8

8859

53544

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.6

41.7

265

701

N99

ICPC

Neurological disease other

2.7

41.7

251

646

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

41.4

175

3263

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

41.4

291

809

R44.3

ICD-10 Finland

Hallucinations, unspecified

4.0

41.2

132

227

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

41.0

4273

23808

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

40.9

1907

9402

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

40.6

7537

44879

-2, ,

ICPC

3.5

40.5

154

300

F0024, G308,

ICD-10 Finland

320.9

40.4

XF606

NOMESCO Finland

Ortostatic test

3.0

40.3

193

437

SPAT1284

SPAT

Extensive health certificate

2.1

40.2

399

1290

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

40.1

7567

45119

L01BC06

ATC

capecitabine; oral

0.4

40.1

165

3112

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

39.9

1172

5263

F22.0

ICD-10 Finland

Delusional disorder

2.6

39.5

253

672

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

39.4

3042

26145

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.0

39.4

439

1485

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

39.2

584

2183

E0000UV, ,

ATC

1.2

39.1

6702

39524

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

39.0

1953

9748

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

39.0

1965

17989

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

38.7

498

1773

G04CB02

ATC

dutasteride; oral

1.4

38.6

1877

9320

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

38.5

6912

40943

F0012, G301,

ICD-10 Finland

+∞

38.5

HA1RA, ,

SPAT

0.2

38.4

2080

K59.0

ICD-10 Finland

Constipation

1.5

38.0

1176

5341

L75

ICPC

Fracture: femur

2.3

37.8

329

1008

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

82.2

37.7

C03CA01

ATC

furosemide; systemic

1.2

37.7

8296

50151

Y94.0

ICD-10 Finland

Accident at home

2.1

37.4

383

1255

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.0

36.9

181

416

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

150.6

36.5

D12

ICPC

Constipation

1.7

36.4

747

3068

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

36.2

1978

17899

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

36.1

426

1472

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

35.8

593

2292

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

147.2

35.6

Z03

ICPC

Housing/neighbourhood problem

3.4

35.5

139

277

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

5.8

35.3

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

5.6

35.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

35.3

1748

S09.9

ICD-10 Finland

Unspecified injury of head

2.3

35.3

277

812

LAITO, ,

NOMESCO Finland

8.6

35.2

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

8.4

35.2

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.0

35.1

386

1300

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

7.6

34.7

R11

ICD-10 Finland

Nausea and vomiting

1.4

34.5

1446

6984

W06

ICD-10 Finland

Fall involving bed

2.6

34.0

216

572

WYA20, ,

SPAT

3.6

34.0

127

245

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

34.0

1363

6527

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

33.6

685

2810

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

51.4

33.3

JN4AD

NOMESCO Finland

Body CT examination

0.7

33.3

1070

10626

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.9

33.0

451

1641

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.4

32.9

133

271

K90

ICPC

Stroke/cerebrovascular accident

1.7

32.8

663

2712

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

32.5

2326

20273

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

8.6

32.5

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

259.0

32.4

C10AX09

ATC

ezetimibe; oral

0.7

32.4

1664

15229

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

32.1

2168

11342

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

31.8

347

4506

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

3.8

31.7

109

198

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

31.5

741

3154

N80

ICPC

Head injury other

2.1

31.4

313

1015

G72.8

ICD-10 Finland

Other specified myopathies

2.1

31.4

341

1144

A98

ICPC

Health maint/preventive medicine

1.3

31.3

16676

108837

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.1

31.2

314

1023

K08.3

ICD-10 Finland

Retained dental root

1.5

31.1

1231

5877

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

31.0

1021

10099

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

4.8

31.0

115

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

31.0

469

1763

SPAT1310

SPAT

Counselling related to known health issue

1.2

31.0

5388

31643

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.3

30.8

260

788

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

30.7

469

1768

W0A10, ,

SPAT

13.7

30.7

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

245.2

30.7

S01.8

ICD-10 Finland

Open wound of other parts of head

2.2

30.4

269

831

SPAT1104

SPAT

Monitoring of emergency patient

1.5

30.0

1191

5690

R35

ICD-10 Finland

Polyuria

1.4

29.9

1314

6397

XF600, ,

SPAT

1.8

29.6

500

1945

A01

ICPC

Pain general/multiple sites

1.4

29.5

1527

7651

TQW40, ,

SPAT

0.6

29.5

462

5404

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

29.5

6490

38954

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

29.2

2282

12179

L03AA13

ATC

pegfilgrastim; parenteral

0.4

29.2

181

2865

SPAT1285

SPAT

Provision of consultation response

1.5

29.2

915

4165

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.5

28.9

908

4134

S28

ICPC

Limited function/disability (S)

2.8

28.9

157

383

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

28.9

320

1081

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

28.9

3330

27413

S22.3

ICD-10 Finland

Fracture of rib

1.5

28.8

1168

5600

EB1VA, ,

NOMESCO Finland

0.6

28.7

685

7242

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

28.3

4202

33689

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

28.1

4170

24050

SPAT1281

SPAT

Other administrative function

1.4

28.0

1256

6135

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

27.9

260

822

R25.1

ICD-10 Finland

Tremor, unspecified

1.7

27.6

549

2237

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

27.6

879

8755

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

27.5

2730

15032

ZXY02

NOMESCO Finland

Neuropsychologist

4.6

27.5

108

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

27.4

503

2005

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

27.2

1307

12107

F0021, G308,

ICD-10 Finland

217.7

27.2

OAB43, ,

SPAT

0.4

27.1

109

2076

SPAT1138

SPAT

Guidance concerning bowel function

2.0

27.1

300

1014

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.4

27.1

107

215

C03DA01

ATC

spironolactone; oral

0.7

26.8

1718

15241

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

26.7

865

3964

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.2

26.6

241

753

S06.3

ICD-10 Finland

Focal brain injury

2.2

26.6

240

749

SPAT1244

SPAT

Occupational therapy

2.4

26.5

201

581

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

26.4

108

2039

A10AE04

ATC

insulin glargine; parenteral

1.3

26.2

1660

8586

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

26.1

4802

28263

EB4VA, ,

NOMESCO Finland

0.5

26.1

344

4220

E000001, ,

ATC

1.3

26.0

2910

16244

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

26.0

7540

46222

S20.2

ICD-10 Finland

Contusion of thorax

1.5

25.9

762

3421

SPAT1127

SPAT

Enema

2.3

25.8

201

589

R74

ICPC

Upper respiratory infection acute

0.8

25.7

1871

16321

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

25.7

8081

49861

P28

ICPC

Limited function/disability (P)

3.3

25.6

109

230

A04AA55

ATC

palonosetron, combinations; systemic

0.3

25.5

1461

I95.9

ICD-10 Finland

Hypotension, unspecified

1.9

25.4

318

1124

WF002

NOMESCO Finland

Radical radiotherapy

0.6

25.2

477

5321

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.9

25.2

320

1137

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

4.5

25.2

105

F0024, G301,

ICD-10 Finland

+∞

25.0

UKC02

NOMESCO Finland

Cystoscopy

1.2

25.0

3618

20775

SPAT1236

SPAT

Informing family of child’s disability

1.9

24.7

344

1260

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

24.7

718

3214

F06.0

ICD-10 Finland

Organic hallucinosis

4.5

24.7

104

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

24.6

1031

4974

N05AH02

ATC

clozapine; systemic

3.1

24.6

115

258

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

6.0

24.5

F0013, G301,

ICD-10 Finland

199.4

24.5

N02AX02

ATC

tramadol; systemic, rectal

0.8

24.4

6288

48103

N06AX21

ATC

duloxetine; oral

1.4

24.4

1389

7065

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

8.4

24.4

Z60.8

ICD-10 Finland

Other problems related to social environment

3.9

24.4

141

N06AX16

ATC

venlafaxine; oral

1.4

24.3

1347

6822

S01BC05

ATC

ketorolac; ophthalmic

1.5

24.1

870

4079

C04AE01

ATC

ergoloid mesylates; systemic

2.4

24.0

175

497

SDA03

NOMESCO Finland

Periodontal treatment

0.8

24.0

3606

28971

KED22

NOMESCO Finland

Transurethral resection of prostate

1.4

23.9

1449

7443

N03AE01

ATC

clonazepam; systemic

1.5

23.8

827

3848

J01MA02

ATC

ciprofloxacin; systemic

1.2

23.5

7371

45360

H02AB06

ATC

prednisolone; systemic

0.9

23.5

7126

53856

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

23.5

178

2608

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

23.4

608

2653

N03AX14

ATC

levetiracetam; systemic

1.7

23.4

416

1644

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

23.3

1587

13983

WW500

NOMESCO Finland

Blood transfusion

0.5

23.3

278

3511

F0022, G308,

ICD-10 Finland

+∞

23.2

R54

ICD-10 Finland

Senility

2.6

23.2

144

378

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

23.2

764

3515

G04BD07

ATC

tolterodine; oral

1.4

23.1

1034

5047

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

3.3

23.1

193

ZX120

NOMESCO Finland

Intravenous

0.7

23.0

901

8651

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

23.0

228

3049

Y94.1

ICD-10 Finland

Accident in connection with service housing

7.2

22.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

22.9

5883

35603

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.4

22.8

173

501

N04BC09

ATC

rotigotine; transdermal

3.3

22.7

192

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.1

22.6

104

231

M01AH05

ATC

etoricoxib; oral

0.9

22.6

7136

53820

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

6.8

22.6

AA1BG, ,

SPAT

2.2

22.5

198

612

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

22.5

110

1915

F0004, G300,

ICD-10 Finland

+∞

22.4

K91

ICPC

Cerebrovascular disease

1.9

22.1

293

1058

I67.4

ICD-10 Finland

Hypertensive encephalopathy

6.8

22.0

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

22.0

833

8044

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

21.8

2159

11859

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

21.8

1889

10203

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

3.6

21.8

150

A78

ICPC

Infectious disease other/NOS

2.3

21.7

182

551

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

92.4

21.6

A11CC03

ATC

alfacalcidol; systemic

0.4

21.6

113

1912

F009, G301,

ICD-10 Finland

+∞

21.5

R45.5

ICD-10 Finland

Hostility

10.4

21.4

JN4BD

NOMESCO Finland

Extensive body CT

0.7

21.4

1246

11231

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.7

21.4

122

307

N05AX12

ATC

aripiprazole; systemic

2.2

21.4

189

586

B01AB10

ATC

tinzaparin; parenteral

0.7

21.3

918

8668

G04CA01

ATC

alfuzosin; oral

1.2

21.2

2532

14215

N19

ICPC

Speech disorder

2.0

21.2

236

801

F32

ICD-10 Finland

Depressive episode

1.7

21.1

444

1840

T08

ICPC

Weight loss

1.9

21.0

276

993

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.6

20.8

491

5205

A10BJ06

ATC

semaglutide; parenteral

0.5

20.7

167

2393

SPAT1325

SPAT

Vaccination

1.2

20.7

6931

42751

R40.2

ICD-10 Finland

Coma, unspecified

2.3

20.6

171

516

XKD00

NOMESCO Finland

Uroflowmetry

1.2

20.6

3546

20674

T05

ICPC

Feeding problem of adult

2.9

20.5

105

249

L76

ICPC

Fracture: other

1.6

20.3

530

2316

L03AA02

ATC

filgrastim; parenteral

0.4

20.2

135

2071

U13

ICPC

Bladder symptom/complaint other

1.6

20.2

503

2174

J96.1

ICD-10 Finland

Chronic respiratory failure

0.5

20.2

160

2306

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

20.1

138

2096

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.9

20.1

284

1048

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

19.7

904

P04

ICPC

Feeling/behaving irritable/angry

4.1

19.7

103

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

19.7

950

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.5

19.5

621

2838

P03

ICPC

Feeling depressed

1.5

19.5

669

3106

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

19.4

956

8841

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.7

19.4

512

5301

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

19.4

1208

C01DA14

ATC

isosorbide mononitrate; oral

1.2

19.3

4337

25875

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.9

19.2

256

926

R45.1

ICD-10 Finland

Restlessness and agitation

4.3

19.2

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.7

19.2

398

1644

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.9

19.2

248

889

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

19.1

2515

14260

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

57.0

19.0

N18

ICPC

Paralysis/weakness

1.7

19.0

369

1497

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.1

19.0

199

661

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

18.8

1717

14598

N07AA06, ,

ATC

+∞

18.8

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

+∞

18.8

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.7

18.8

337

1338

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

18.7

514

2274

N04BC05

ATC

pramipexole; oral

1.3

18.6

1334

7020

A10BK03

ATC

empagliflozin; oral

0.7

18.6

903

8369

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

4.5

18.6

G04BD09

ATC

trospium; oral

1.6

18.5

480

2097

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.8

18.5

282

1067

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

18.4

2865

16519

G40

ICD-10 Finland

Epilepsy

2.6

18.4

114

300

U28

ICPC

Limited function/disability (U)

2.0

18.4

222

777

C10AA07

ATC

rosuvastatin; oral

0.8

18.4

4093

31869

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

18.3

1982

10993

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

4.0

18.3

M04AA01

ATC

allopurinol; systemic

0.8

18.1

2150

17757

SPAT1240

SPAT

Therapeutic discussion

1.4

18.1

841

4134

A10BH05

ATC

linagliptin; oral

1.4

18.1

1076

5509

S01

ICD-10 Finland

Open wound of head

2.0

17.9

202

690

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

17.9

868

4300

SPAT1255

SPAT

Intravenous administration of medicine

1.3

17.8

1137

5882

F0232, G20,

ICD-10 Finland

26.4

17.8

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.4

17.8

758

3669

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.0

17.8

209

725

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.9

17.8

249

917

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

17.8

2436

19824

F0230, G20,

ICD-10 Finland

19.8

17.7

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

17.7

2798

22461

XQ855, ,

SPAT

2.3

17.6

143

428

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

17.6

779

3798

B01AA03

ATC

warfarin; systemic

1.2

17.5

4924

29879

T03

ICPC

Loss of appetite

3.2

17.5

167

N04AA02

ATC

biperiden; systemic

1.9

17.4

218

773

F01.8

ICD-10 Finland

Other vascular dementia

4.4

17.3

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.5

17.3

127

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.0

17.3

188

634

A99

ICPC

Disease/condition unspecnature/site

1.3

17.2

1498

8089

SPAT1097

SPAT

Recording of ECG

1.2

17.1

2801

16222

HA1AA, ,

SPAT

0.3

17.1

1075

R01AD58

ATC

fluticasone, combinations; nasal

0.8

17.0

1430

12286

SPAT1081

SPAT

Cardiorespiratory global assessment

1.3

17.0

1087

5626

A10BB12

ATC

glimepiride; oral

1.3

17.0

1578

8592

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.7

16.9

101

261

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

4.6

16.9

L15

ICPC

Knee symptom/complaint

0.8

16.9

2740

21958

SPAT1042

SPAT

Guidance concerning balance maintenance

2.5

16.9

114

314

A10BK01

ATC

dapagliflozin; oral

0.7

16.8

599

5851

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

16.8

125

1838

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

16.7

1632

13780

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

5.1

16.7

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.6

16.7

255

3001

B01AC07

ATC

dipyridamole; systemic

1.3

16.7

1198

6304

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.6

16.7

431

1882

F02.8

ICD-10 Finland

Dementia in other specified diseases classified elsewhere

136.8

16.6

F0023, G308,

ICD-10 Finland

136.8

16.6

KMAK, ,

NOMESCO Finland

1.1

16.6

6404

39739

EBA00

NOMESCO Finland

Extraction of tooth

1.2

16.6

4868

29618

Z11

ICPC

Compliance/being ill problem

2.5

16.5

113

313

S82

ICPC

Naevus/mole

0.8

16.5

1244

10837

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.6

16.4

415

4334

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.5

16.4

141

1970

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

16.3

1564

S42.0

ICD-10 Finland

Fracture of clavicle

1.6

16.3

353

1475

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

16.3

321

3545

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.2

16.3

143

443

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.7

16.3

456

4664

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

16.3

1080

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

3.2

16.2

150

R18

ICD-10 Finland

Ascites

0.4

16.2

1490

A12AA04

ATC

calcium carbonate; oral

0.3

16.2

1179

Z51.88

ICD-10 Finland

Other specified medical care

1.7

16.1

338

1401

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

16.0

777

7203

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

15.9

1202

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

15.9

1470

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.7

15.9

650

6198

C10AA02

ATC

lovastatin; oral

1.4

15.8

920

4694

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

1.9

15.8

215

785

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.4

15.8

815

4080

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.5

15.8

203

2502

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.9

15.8

4619

35296

N03AF02

ATC

oxcarbazepine; oral

1.6

15.7

407

1779

R2110

NOMESCO Finland

Giving the first information

1.4

15.7

760

3764

A23

ICPC

Risk factor NOS

1.4

15.7

786

3915

R03AC02

ATC

salbutamol; inhalant

0.9

15.7

7146

52998

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

15.7

617

5920

R31

ICD-10 Finland

Unspecified haematuria

1.2

15.6

2155

12263

F02.3

ICD-10 Finland

Dementia in Parkinson disease

68.4

15.6

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

3.0

15.6

165

M25.5

ICD-10 Finland

Pain in joint

0.8

15.5

3079

24261

D17

ICPC

Incontinence of bowel

2.0

15.5

182

632

M02AA07

ATC

piroxicam; topical

1.1

15.4

6504

40555

U29

ICPC

Urinary symptom/complaint other

1.5

15.4

505

2326

H91.1

ICD-10 Finland

Presbycusis

1.3

15.4

1598

8818

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

15.3

734

3628

G04BD10

ATC

darifenacin; oral

2.2

15.3

136

424

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

15.3

1309

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.7

15.3

423

4333

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

15.2

295

3269

XQ858, ,

SPAT

2.9

15.2

182

Z00.0

ICD-10 Finland

General medical examination

1.2

15.2

3070

18105

GD1AA, ,

SPAT

0.6

15.2

349

3720

NF3AA

NOMESCO Finland

Femur X-ray examination

1.6

15.2

375

1620

F0019, G309,

ICD-10 Finland

+∞

15.2

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.8

15.2

1572

13190

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.4

15.1

842

4266

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

15.1

1240

6644

R06.0

ICD-10 Finland

Dyspnoea

0.9

15.0

4101

31521

NG1AA, ,

SPAT

0.5

15.0

125

1764

Z08

ICPC

Social welfare problem

2.1

14.9

143

460

TK800

NOMESCO Finland

Hemodialysis

0.4

14.9

1431

D07AA02

ATC

hydrocortisone; topical

1.2

14.9

1758

9838

Z75.0

ICD-10 Finland

Medical services not available in home

3.3

14.9

130

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.7

14.9

300

1232

Q90.9

ICD-10 Finland

Down syndrome, unspecified

123.1

14.9

Z51.5

ICD-10 Finland

Palliative care

1.2

14.8

1671

9305

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.5

14.8

133

1830

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

7.1

14.8

P18

ICPC

Medication abuse

3.4

14.8

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.7

14.8

415

4239

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.7

14.7

440

4437

N07

ICPC

Convulsion/seizure

4.5

14.7

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

14.6

680

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

3.2

14.5

129

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.1

14.5

5836

36243

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

14.5

269

3008

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.1

14.4

140

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

14.3

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

14.2

749

3762

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.6

14.2

342

3606

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

14.1

2713

15923

F02.82

ICD-10 Finland

Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations

34.2

14.1

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

14.0

1531

8494

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.5

13.9

489

2284

A10AE05

ATC

insulin detemir; parenteral

1.4

13.9

775

3929

359

Kela drug reimbursment

Mirabegroni

2.2

13.9

119

366

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

13.9

963

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

13.8

3870

23413

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.6

13.8

194

2328

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.6

13.7

226

2604

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

13.7

636

3128

S32.5

ICD-10 Finland

Fracture of pubis

1.9

13.7

184

670

G46.8

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

7.1

13.7

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.0

13.7

145

486

GD1AD

NOMESCO Finland

Thorax CT examination

0.7

13.7

532

5113

WYA30, ,

SPAT

2.5

13.6

258

A07

ICPC

Coma

2.7

13.6

202

Angiography of the heart and coronary arteries

1.2

13.6

1515

8424

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.7

13.5

398

4025

SPAT1394

SPAT

Counselling and guidance related to living conditions

3.0

13.5

146

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

6.4

13.5

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.6

13.5

223

F0001, G300,

ICD-10 Finland

+∞

13.4

F000, G300,

ICD-10 Finland

+∞

13.4

G04BX04, ,

ATC

1.6

13.4

327

1411

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.3

13.3

952

5009

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.8

13.2

803

7204

G04BD11

ATC

fesoterodine; oral

1.4

13.2

536

2574

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

3.4

13.2

102

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.5

13.2

145

1869

128

Kela drug reimbursment

Cancers of female genital organs

0.4

13.2

1129

F0021, G301,

ICD-10 Finland

109.4

13.1

Z74.1

ICD-10 Finland

Need for assistance with personal care

7.5

13.1

J01FA09

ATC

clarithromycin; systemic

0.9

13.0

3094

24069

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

13.0

794

R01AD59

ATC

mometasone, combinations; nasal

0.4

13.0

1082

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

4.0

12.9

A69.2

ICD-10 Finland

Lyme disease

0.7

12.9

405

4047

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

1.9

12.9

158

559

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

12.8

594

2922

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.4

12.8

997

N04BB01

ATC

amantadine; oral

1.8

12.8

216

845

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.3

12.8

283

R4120, ,

SPAT

2.1

12.8

128

420

AA1AA

NOMESCO Finland

Head X-ray examination

2.0

12.8

138

466

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.7

12.7

230

918

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.2

12.7

111

345

J01FA10

ATC

azithromycin; systemic

0.9

12.7

6218

46095

D19

ICPC

Teeth/gum symptom/complaint

0.8

12.7

2365

18763

G21.8

ICD-10 Finland

Other secondary parkinsonism

3.5

12.6

SPAT1111

SPAT

Planning of analgesia

1.8

12.6

182

679

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.6

12.6

168

2047

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

2.0

12.6

146

506

N05AB03

ATC

perphenazine; systemic, rectal

1.5

12.6

373

1683

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.3

12.6

737

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.3

12.6

109

K03.66

ICD-10 Finland

Tooth plaque

1.3

12.6

914

4821

4289X

ICD-9 Finland

Heart failure, unspecified

0.2

12.5

565

N05CD07

ATC

temazepam; oral

1.2

12.5

2474

14548

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.5

12.5

1334

F02.84

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere as other mixed symptoms of mixed type

30.8

12.5

S01.3

ICD-10 Finland

Open wound of ear

1.8

12.4

178

663

L01CA04

ATC

vinorelbine; systemic

0.2

12.4

620

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

12.4

608

R4190

NOMESCO Finland

Nutritional therapy

0.5

12.4

131

1707

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.4

12.4

681

3448

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.7

12.3

254

1051

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

12.3

303

3176

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.2

12.3

660

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.5

12.2

218

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

3.9

12.2

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.5

12.2

377

1717

115

Kela drug reimbursment

Breast cancer

0.8

12.2

720

6480

N88

ICPC

Epilepsy

2.5

12.1

211

HA1AA

NOMESCO Finland

X-ray mammography

0.7

12.1

607

5597

SGB30

NOMESCO Finland

Other complicated root filling

0.7

12.1

367

3688

WZA30

NOMESCO Finland

Assessment of driving capacity and statement

21.7

12.1

250, ,

Kela drug reimbursment

0.4

12.1

1107

G47.3

ICD-10 Finland

Sleep apnoea

0.8

12.0

2149

17116

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

12.0

1532

8644

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

4.4

12.0

U08

ICPC

Urinary retention

1.5

11.9

383

1759

L03AA14

ATC

lipegfilgrastim; parenteral

0.4

11.9

953

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.5

11.9

221

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

11.9

309

1355

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.7

11.8

214

855

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.3

11.8

285

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.3

11.8

711

L01CB01

ATC

etoposide; systemic

0.1

11.8

334

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.1

11.8

335

A05

ICPC

Feeling ill

1.4

11.8

560

2769

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.2

11.7

563

C09AA05

ATC

ramipril; oral

1.1

11.7

5355

33429

Z01.8

ICD-10 Finland

Other specified special examinations

1.2

11.7

3393

20558

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.6

11.6

300

1313

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

2.2

11.6

305

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

11.5

1469

12075

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

11.5

509

Z60.2

ICD-10 Finland

Living alone

5.1

11.5

SPF30

NOMESCO Finland

Relining of denture

1.5

11.5

340

1536

A06

ICPC

Fainting/syncope

1.7

11.4

216

874

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

11.4

698

L02BG04

ATC

letrozole; oral

0.7

11.4

491

4639

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

11.4

462

2221

B01AC04

ATC

clopidogrel; oral

1.1

11.4

3626

22105

N06AX12

ATC

bupropion; oral

1.6

11.4

303

1336

N04BX04

ATC

opicapone; oral

3.5

11.4

G03DC02

ATC

norethisterone; oral

0.8

11.3

742

6584

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

11.3

118

395

S01.2

ICD-10 Finland

Open wound of nose

1.7

11.2

204

817

N04BC06

ATC

cabergoline; oral

2.7

11.2

159

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.5

11.2

199

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.5

11.2

334

1512

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.7

11.2

379

3728

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

11.1

136

1694

S51.0

ICD-10 Finland

Open wound of elbow

1.7

11.1

190

749

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.5

11.0

303

1346

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.5

11.0

1171

R21

ICPC

Throat symptom/complaint

0.8

11.0

1270

10542

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

10.9

1662

9542

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

10.9

1093

6004

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.9

10.9

3993

30194

W18

ICD-10 Finland

Other fall on same level

2.1

10.9

102

327

T93

ICPC

Lipid disorder

0.7

10.9

609

5523

D82

ICPC

Teeth/gum disease

0.9

10.9

3305

25296

G04BD04

ATC

oxybutynin; oral, transdermal

1.3

10.8

1014

5527

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.2

10.8

279

D21

ICPC

Swallowing problem

1.6

10.8

248

1057

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.3

10.8

1049

5745

I95.2

ICD-10 Finland

Hypotension due to drugs

1.9

10.8

144

526

P99

ICPC

Psychological disorders other

1.8

10.7

172

665

I50.1

ICD-10 Finland

Left ventricular failure

0.8

10.7

715

6328

R03BB01

ATC

ipratropium bromide; inhalant

0.7

10.6

533

4914

ZX120, ,

SPAT

1.9

10.6

144

528

XJH00

NOMESCO Finland

Transanal ultrasonography

1.2

10.6

1313

7384

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

10.6

253

2667

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.1

10.6

3423

20879

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

3.8

10.6

Z43.5

ICD-10 Finland

Attention to cystostomy

1.9

10.5

130

462

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

10.5

506

2508

F0280, G318,

ICD-10 Finland

19.4

10.5

H04AA01

ATC

glucagon; nasal, parenteral

1.9

10.5

143

525

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.3

10.5

992

5412

XA400

NOMESCO Finland

EEG

2.3

10.5

252

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.7

10.5

209

859

G03AC03

ATC

levonorgestrel; oral, implant

0.7

10.5

285

2924

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.3

10.5

231

C10AA05

ATC

atorvastatin; oral

1.1

10.4

8226

52835

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

3.0

10.4

108

TGC00

NOMESCO Finland

Bronchial lavation

0.6

10.4

175

2001

S06.2

ICD-10 Finland

Diffuse brain injury

1.9

10.4

129

459

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

1.8

10.4

146

542

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

10.4

291

OAA80, ,

SPAT

0.2

10.3

540

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.9

10.3

2093

16506

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.2

10.3

1121

6220

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.4

10.3

1017

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.8

10.2

163

629

WX290

NOMESCO Finland

Other blockage of nerve

0.9

10.2

3804

28755

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

1.3

10.2

588

3000

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.2

10.2

1467

8379

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

10.1

716

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.5

10.1

1200

R03BA08

ATC

ciclesonide; inhalant

0.8

10.1

639

5693

S16

ICPC

Bruise/contusion

1.4

10.0

511

2558

A10AD05

ATC

insulin aspart; parenteral

1.5

10.0

370

1750

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.8

10.0

823

7094

R50.9

ICD-10 Finland

Fever, unspecified

1.2

10.0

2242

13312

A04AD12

ATC

aprepitant; systemic

0.4

10.0

920

F01.14

ICD-10 Finland

Multi-infarct dementia's other mixed symptoms of mixed type

5.7

10.0

R5120

NOMESCO Finland

Preparation of an aid

1.4

9.9

501

2504

F01.0

ICD-10 Finland

Vascular dementia of acute onset

2.7

9.9

138

F30.1

ICD-10 Finland

Mania without psychotic symptoms

5.0

9.9

M76.6

ICD-10 Finland

Achilles tendinitis

0.7

9.9

268

2750

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.5

9.9

1308

D64.9

ICD-10 Finland

Anaemia, unspecified

1.2

9.9

2270

13503

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

1.9

9.9

136

502

SPAT1063

SPAT

Suctioning of mucus from airways

3.5

9.9

F0014, G309,

ICD-10 Finland

+∞

9.8

K02.0

ICD-10 Finland

Caries limited to enamel

0.8

9.8

957

8090

T82

ICPC

Obesity

0.5

9.8

1293

G03CA04

ATC

estriol; systemic, vaginal

1.2

9.7

1420

8120

PA7BD

NOMESCO Finland

CT angiography of neck and brain

1.6

9.7

243

1058

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

9.7

429

4032

F0289, G318,

ICD-10 Finland

44.4

9.7

E66.00

ICD-10 Finland

Metabolic syndrome

0.7

9.7

342

3338

D07AC01

ATC

betamethasone; topical

1.1

9.7

5622

35501

R44.0

ICD-10 Finland

Auditory hallucinations

2.5

9.7

176

WZC30, ,

SPAT

0.7

9.7

436

4085

U05

ICPC

Urination problems other

1.3

9.7

902

4915

D22

ICD-10 Finland

Melanocytic naevi

0.6

9.7

170

1920

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

9.7

339

1588

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

9.7

1602

12854

N18.0

ICD-10 Finland

End-stage renal disease

0.4

9.7

878

B04AB02, ,

ATC

1.4

9.7

417

2031

P15

ICPC

Chronic alcohol abuse

1.6

9.6

201

837

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

5.5

9.6

F38

ICPC

Eye, Other laboratory test NEC

0.5

9.6

1010

OAB76, ,

SPAT

2.9

9.6

114

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.7

9.6

427

4005

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.7

9.5

315

3108

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.4

9.5

862

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

0.7

9.5

458

4242

S32.4

ICD-10 Finland

Fracture of acetabulum

1.9

9.5

130

480

M03BX02

ATC

tizanidine; oral

0.9

9.5

7219

52507

R2130, ,

SPAT

1.9

9.5

123

446

OAB48, ,

SPAT

0.6

9.4

126

1527

P19

ICPC

Drug abuse

3.1

9.4

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.5

9.4

1177

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

1.8

9.4

133

496

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

0.8

9.4

1056

8787

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

2.5

9.3

159

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.4

9.3

826

ZX080

NOMESCO Finland

Image guided radiotherapy

0.5

9.3

110

1381

S01.7

ICD-10 Finland

Multiple open wounds of head

2.0

9.3

325

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

9.3

12929

85157

L02BG06

ATC

exemestane; oral

0.5

9.3

969

A49

ICPC

General and Unspecified, Other preventive procedure

1.9

9.3

116

415

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.4

9.3

430

2121

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

0.5

9.3

1043

Z01.2

ICD-10 Finland

Dental examination

0.9

9.3

4707

34971

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.2

9.3

240

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

23.9

9.3

Y94.8

ICD-10 Finland

Other leisure activity accident

1.5

9.2

330

1552

WX722

NOMESCO Finland

PEEP

0.7

9.2

396

3738

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.5

9.2

104

1322

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.6

9.2

184

2013

F01.22

ICD-10 Finland

Subcortical vascular dementia with additional symptoms, mainly hallucinations

5.0

9.2

M02AA10

ATC

ketoprofen; topical

1.2

9.2

2444

14700

127

Kela drug reimbursment

Transplant complication

0.3

9.2

566

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.5

9.2

263

1183

C10AA04

ATC

fluvastatin; oral

1.2

9.2

1827

10745

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

9.1

465

4273

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

4.8

9.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

9.1

192

2073

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.8

9.0

654

5725

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.5

9.0

321

1510

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

9.0

1127

9277

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.8

9.0

542

4858

F0001, G301,

ICD-10 Finland

+∞

8.9

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.3

8.9

851

4652

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

0.4

8.9

691

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.6

8.9

226

990

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

8.9

781

4229

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

0.4

8.8

648

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

1.7

8.8

178

736

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.8

8.8

594

5248

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

3.1

8.8

A06AH03

ATC

naloxegol; oral

0.5

8.8

949

R51.80

ICD-10 Finland

Headache

1.2

8.8

1624

9488

Z50

ICD-10 Finland

Care involving use of rehabilitation procedures

3.9

8.8

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

0.6

8.8

172

1889

-31

ICPC

Medical examin/health eval partial

1.2

8.8

1090

6137

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

1.7

8.7

156

624

I67.2

ICD-10 Finland

Cerebral atherosclerosis

2.0

8.7

324

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

2.0

8.7

301

SPAT1165

SPAT

Peritoneal dialysis

2.8

8.7

109

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

8.7

356

3384

SPAT1109

SPAT

Analgesia with portable analgesic pump

1.9

8.7

109

391

S02.51

ICD-10 Finland

Fracture of tooth, open

0.8

8.7

666

5787

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

1.3

8.7

516

2650

R41.2

ICD-10 Finland

Retrograde amnesia

3.7

8.7

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

2.0

8.7

325

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.1

8.6

5496

34833

TPH04, ,

SPAT

2.0

8.6

330

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

2.3

8.6

195

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

0.8

8.6

525

4701

N84.0

ICD-10 Finland

Polyp of corpus uteri

0.8

8.6

491

4437

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

0.3

8.6

568

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.2

8.6

257

R01AD12

ATC

fluticasone furoate; nasal

0.9

8.6

2390

18432

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.5

8.6

931

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.5

8.6

959

S97

ICPC

Chronic ulcer skin

1.2

8.6

1094

6174

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

0.6

8.6

134

1556

L04AA06

ATC

mycophenolic acid; systemic

0.4

8.6

778

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.8

8.6

1279

10360

AA1ED

NOMESCO Finland

Trauma CT of head and neck

2.1

8.6

253

F32.0

ICD-10 Finland

Mild depressive episode

1.6

8.5

205

886

WX111

NOMESCO Finland

Local infiltration anesthesia

0.7

8.5

299

2918

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.8

8.5

533

4754

TQW40

NOMESCO Finland

Remowal of suture of skin

0.8

8.5

591

5200

TFP34

NOMESCO Finland

Electrophysiological investigation

0.6

8.5

147

1664

SDA05

NOMESCO Finland

Very demanding periodontal treatment

0.7

8.5

318

3068

Z49.0

ICD-10 Finland

Preparatory care for dialysis

0.4

8.5

615

G03FB05

ATC

norethisterone and estrogen; systemic

0.8

8.5

1035

8542

T11

ICPC

Dehydration

3.2

8.5

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

0.7

8.5

216

2239

N03AX18

ATC

lacosamide; systemic

2.2

8.5

232

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

1.7

8.4

152

610

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.2

8.4

1054

5937

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

1.8

8.4

139

544

ZYC01, ,

SPAT

1.2

8.4

888

4912

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.5

8.4

932

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.9

8.4

2585

19800

Z59.8

ICD-10 Finland

Other problems related to housing and economic circumstances

3.8

8.4

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

0.3

8.4

474

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

2.2

8.4

242

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

1.7

8.4

170

705

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

0.8

8.4

606

5302

SPAT1058

SPAT

PEF monitoring instruction

0.8

8.3

842

7088

N03AX09

ATC

lamotrigine; oral

1.5

8.3

270

1247

R00.2

ICD-10 Finland

Palpitations

0.8

8.3

540

4791

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

0.5

8.3

1165

ZXA00

NOMESCO Finland

Right side

1.1

8.3

4825

30432

L57.0

ICD-10 Finland

Actinic keratosis

0.9

8.3

1830

14349

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.3

8.2

612

3244

S01EX03, ,

ATC

1.4

8.2

445

2253

137

Kela drug reimbursment

Uraemia requiring dialysis

0.3

8.2

447

L02BB04

ATC

enzalutamide; oral

0.5

8.2

840

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.3

8.2

574

HA1AE, ,

SPAT

0.3

8.2

511

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

1.7

8.2

152

616

Z51.0

ICD-10 Finland

Radiotherapy session

0.5

8.2

950

WX723

NOMESCO Finland

CPAP therapy

0.6

8.1

167

1814

L04AX03

ATC

methotrexate; systemic

0.8

8.1

786

6648

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

10.9

8.1

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

8.1

798

6737

F01.33

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression

7.2

8.1

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

0.5

8.1

948

K88

ICPC

Postural hypotension

1.7

8.1

161

664

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.7

8.1

152

618

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

0.2

8.1

289

S72.8

ICD-10 Finland

Fractures of other parts of femur

2.2

8.1

219

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

8.1

711

3853

XX2RW, ,

NOMESCO Finland

0.3

8.1

569

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.2

8.1

1175

6722

SPAT1243

SPAT

Psychiatric/psychological examination

1.8

8.0

120

456

F0002, G300,

ICD-10 Finland

+∞

8.0

F0009, G309,

ICD-10 Finland

+∞

8.0

R03AK08

ATC

formoterol and beclometasone; inhalant

0.7

8.0

276

2702

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.7

8.0

217

2223

D07AB02

ATC

hydrocortisone butyrate; topical

1.1

8.0

4319

27119

S21

ICPC

Skin texture symptom/complaint

0.9

8.0

1751

13745

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

0.4

8.0

659

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.9

8.0

354

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.3

8.0

176

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

0.1

8.0

179

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

1.4

8.0

364

1793

L08

ICPC

Shoulder symptom/complaint

0.9

8.0

2552

19505

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.1

8.0

3789

23630

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

8.0

218

972

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

8.0

6007

43818

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

0.2

8.0

245

L01AX03

ATC

temozolomide; systemic

0.2

7.9

283

F02.89

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without information of additional symptoms

5.0

7.9

114

Kela drug reimbursment

Glaucoma

1.2

7.9

1921

11472

SGA01

NOMESCO Finland

Emergency treatment

0.8

7.9

866

7226

OAB95, ,

SPAT

0.3

7.9

501

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

0.7

7.9

229

2311

Z00.8

ICD-10 Finland

Other general examinations

1.2

7.9

975

5489

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

0.7

7.8

261

2569

H40.9

ICD-10 Finland

Glaucoma, unspecified

1.4

7.8

331

1609

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.7

7.8

151

618

ZXC96

NOMESCO Finland

Robot assisted procedure

0.6

7.8

151

1663

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

0.4

7.8

681

ACC51

NOMESCO Finland

Release of median nerve

0.8

7.8

557

4883

SPAT1232

SPAT

Communication with help of interpreter or assistant

2.7

7.8

112

G03FB08

ATC

dydrogesterone and estrogen; systemic

0.7

7.8

205

2111

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.4

7.8

285

1349

F01.32

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations

9.9

7.8

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

0.2

7.8

242

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

0.5

7.8

832

Z93.5

ICD-10 Finland

Cystostomy status

2.3

7.7

166

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

0.4

7.7

697

163

Kela drug reimbursment

Abiraterone and enzalutamide

0.5

7.7

914

R26

ICD-10 Finland

Abnormalities of gait and mobility

2.4

7.7

162

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.7

7.7

394

3614

Z94.0

ICD-10 Finland

Kidney transplant status

0.3

7.7

430

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

0.5

7.7

1022

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

5.1

7.7

A86

ICD-10 Finland

Unspecified viral encephalitis

2.2

7.7

210

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.8

7.7

477

4257

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.6

7.7

117

1365

D06

ICPC

Abdominal pain localized other

0.8

7.7

707

6009

E87.6

ICD-10 Finland

Hypokalaemia

1.3

7.7

503

2623

S30.1

ICD-10 Finland

Contusion of abdominal wall

1.7

7.7

155

643

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

0.5

7.6

956

AA1FD

NOMESCO Finland

Trauma CT of head and face

3.4

7.6

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.4

7.6

544

-, ,

ICD-10 Finland

1.4

7.6

329

1606

T68

ICD-10 Finland

Hypothermia

2.1

7.6

238

E66

ICD-10 Finland

Obesity

0.6

7.6

144

1592

M05BA02

ATC

clodronic acid; systemic

0.3

7.6

415

N02BF01

ATC

gabapentin; oral

0.8

7.6

700

5948

S06.9

ICD-10 Finland

Intracranial injury, unspecified

1.9

7.6

313

N30

ICD-10 Finland

Cystitis

1.2

7.5

949

5352

TPH07

NOMESCO Finland

Cathetrisation of artery

0.9

7.5

1488

11769

K28

ICPC

Limited function/disability (K)

1.4

7.5

406

2057

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.3

7.5

654

3540

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.2

7.5

836

4655

M03AX01

ATC

botulinum toxin; parenteral

2.4

7.5

160

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

7.5

103

382

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.4

7.5

389

1959

ZXA05

NOMESCO Finland

Left side

1.1

7.5

4509

28466

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

7.5

476

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.2

7.5

1322

7697

SPAT1277

SPAT

Instruction concerning legal protection and patient’s rights

3.1

7.5

Z10.0

ICD-10 Finland

Occupational health examination

0.5

7.5

782

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

0.1

7.5

171

OAB41, ,

SPAT

1.9

7.5

310

F91.9

ICD-10 Finland

Conduct disorder, unspecified

12.0

7.5

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

0.5

7.4

883

N05AN01

ATC

lithium; oral

1.6

7.4

167

712

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.5

7.4

1027

I95

ICD-10 Finland

Hypotension

1.9

7.4

311

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.2

7.4

374

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.3

7.3

689

3764

F01.89

ICD-10 Finland

Other specified vascular dementia without information on additional symptoms

4.6

7.3

AA1AG, ,

SPAT

4.6

7.3

B01AC24

ATC

ticagrelor; oral

0.7

7.3

308

2910

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.4

7.3

310

1509

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.3

7.3

438

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.8

7.3

505

4441

K80

ICPC

Cardiac arrhythmia NOS

0.8

7.3

919

7559

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.7

7.3

131

527

IGP01

NOMESCO Finland

Psychiatric family contact

2.8

7.3

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.3

7.3

713

3915

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

0.4

7.3

530

P01

ICPC

Feeling anxious/nervous/tense

1.3

7.2

570

3047

IGV01

NOMESCO Finland

Psychiatric network contact

2.7

7.2

101

C09CA06

ATC

candesartan; oral

0.9

7.2

2907

21922

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.4

7.2

323

1587

R03DA04

ATC

theophylline; systemic, rectal

0.8

7.2

784

6544

ZXD35

NOMESCO Finland

Usual procedure

1.3

7.2

445

2302

G91.1

ICD-10 Finland

Obstructive hydrocephalus

2.3

7.2

159

SGA02

NOMESCO Finland

Opening and preparing the root canals

0.8

7.2

968

7912

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

7.2

1002

8161

F0003, G300,

ICD-10 Finland

+∞

7.2

F0010, G308,

ICD-10 Finland

+∞

7.2

F0022, G301,

ICD-10 Finland

+∞

7.2

D06BB10

ATC

imiquimod; topical

0.8

7.1

516

4511

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

7.1

1670

9948

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.3

7.1

627

3400

C07AB02

ATC

metoprolol; systemic

1.1

7.1

4487

28384

F009, G308,

ICD-10 Finland

61.5

7.1

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

0.4

7.1

690

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

1.5

7.1

252

1189

5509B

ICD-9 Finland

Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,LATERALIS (SCROT]

1.4

7.1

363

1826

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.3

7.1

463

2416

R07.4

ICD-10 Finland

Chest pain, unspecified

1.1

7.0

4849

30801

191

Kela drug reimbursment

Erlotinib

0.1

7.0

181

WX780

NOMESCO Finland

Remote monitoring CPAP

0.7

7.0

194

1975

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

0.3

7.0

428

B03XA01

ATC

erythropoietin; parenteral

0.4

7.0

678

Z27

ICPC

Fear of a social problem

2.5

7.0

119

JAH01

NOMESCO Finland

Laparoscopy

0.7

7.0

227

2241

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.1

7.0

4482

28372

EB1SA, ,

SPAT

0.7

7.0

206

2070

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

0.7

7.0

180

1857

S18

ICPC

Laceration/cut

0.9

7.0

7222

52036

SPAT1324

SPAT

Screening procedure

0.7

7.0

325

3019

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.1

7.0

2676

16478

NB1BG, ,

SPAT

0.3

7.0

426

F0020, G301,

ICD-10 Finland

18.8

6.9

AA5NK

NOMESCO Finland

Tractography within white matter of central nervous system

18.8

6.9

XW000

NOMESCO Finland

Bone marrow biopsy

0.8

6.9

409

3670

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

0.6

6.9

1083

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

0.5

6.9

823

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.9

6.9

2195

16788

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.5

6.9

205

933

N07CA01

ATC

betahistine; oral

1.2

6.9

1207

7024

322

Kela drug reimbursment

Sunitinib

0.0

6.9

120

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

3.4

6.9

A10BX01

ATC

guar gum; oral

1.2

6.9

723

4003

G41.9

ICD-10 Finland

Status epilepticus, unspecified

1.9

6.8

291

R10.1

ICD-10 Finland

Pain localized to upper abdomen

0.9

6.8

1847

14280

N05CF01

ATC

zopiclone; oral

1.1

6.8

5949

38185

K03.11

ICD-10 Finland

Abrasion dentifrice of teeth

0.6

6.8

121

1356

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.9

6.8

2969

22292

NG1BG, ,

SPAT

0.4

6.8

514

N06BA07

ATC

modafinil; oral

4.3

6.8

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

1.6

6.8

166

723

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.3

6.8

620

3378

A02

ICPC

Chills

1.9

6.8

321

A06AC51

ATC

ispaghula, combinations; oral

1.3

6.8

667

3666

K05.30

ICD-10 Finland

Periodontitis complex

0.9

6.8

1466

11513

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

1.5

6.7

200

910

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

6.7

244

2360

S82.0

ICD-10 Finland

Fracture of patella

1.5

6.7

223

1039

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.9

6.7

284

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

0.7

6.7

180

1840

X09

ICD-10 Finland

Exposure to unspecified smoke, fire and flames

3.0

6.7

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.8

6.7

717

5990

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

0.3

6.7

437

K03.00

ICD-10 Finland

Approximal wear

0.8

6.7

381

3434

55099

ICD-8 Finland

Inguinal hernia without mention of obstruction

1.3

6.7

649

3563

R12

ICD-10 Finland

Heartburn

0.8

6.6

649

5477

F0282, G318,

ICD-10 Finland

22.8

6.6

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.8

6.6

1020

8236

SPAT1335

SPAT

Plan for further care, organisation of further care

1.6

6.6

141

594

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

0.5

6.6

672

N43

ICPC

Neurological, Other diagnostic procedure

1.9

6.6

271

R60.0

ICD-10 Finland

Localized oedema

1.1

6.6

2183

13317

SGC00

NOMESCO Finland

Medication, disinfection of root canals

0.8

6.6

593

5050

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

6.6

496

E44.1

ICD-10 Finland

Mild protein-energy malnutrition

3.9

6.6

SPAT1396

SPAT

Meeting with multidisciplinary group of experts

3.9

6.6

L02BA01

ATC

tamoxifen; oral

0.7

6.6

262

2495

R02

ICPC

Shortness of breath/dyspnoea

0.9

6.6

1736

13444

S50.0

ICD-10 Finland

Contusion of elbow

1.4

6.6

253

1212

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

0.8

6.6

475

4151

PJA10

NOMESCO Finland

Exploration of lymph nodes

0.5

6.6

772

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

2.2

6.6

166

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

0.1

6.6

170

V613A

ICD-9 Finland

Other family circumstances, Problems with aged parents or in-laws

7.9

6.6

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

1.9

6.5

291

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

2.5

6.5

115

I95.0

ICD-10 Finland

Idiopathic hypotension

2.5

6.5

111

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

0.5

6.5

734

N06BA04

ATC

methylphenidate; oral

2.6

6.5

107

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

0.6

6.5

1030

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

0.7

6.5

180

1830

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.6

6.5

101

1169

R05

ICPC

Cough

0.9

6.5

2797

21021

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.6

6.5

134

560

D07CC01

ATC

betamethasone and antibiotics; topical

1.2

6.5

1611

9636

K78

ICPC

Atrial fibrillation/flutter

1.2

6.5

1698

10196

183

Kela drug reimbursment

Lamotrigin and topiramate

2.0

6.5

221

ZX112

NOMESCO Finland

Subcutaneous

0.6

6.5

143

1523

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

0.4

6.5

502

IHA10, ,

SPAT

1.7

6.5

106

416

N02CD02

ATC

galcanezumab; parenteral

8.7

6.5

T89

ICPC

Diabetes insulin dependent

1.4

6.5

324

1625

K29

ICPC

Cardiovascular sympt/complt other

1.2

6.5

760

4260

U70

ICPC

Pyelonephritis/pyelitis

1.5

6.5

185

836

EB1AA, ,

SPAT

0.8

6.4

399

3555

N03AB02

ATC

phenytoin; systemic

1.5

6.4

170

755

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.3

6.4

360

1838

159

Kela drug reimbursment

Pazopanib

0.1

6.4

133

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

0.6

6.4

149

1569

SCA02

NOMESCO Finland

Preventive oral health care

1.2

6.4

947

5430

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

0.2

6.4

237

G04BE04

ATC

yohimbine; oral

1.6

6.4

155

675

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

0.7

6.4

159

1649

N21.0

ICD-10 Finland

Calculus in bladder

1.5

6.4

168

746

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

0.7

6.4

278

2606

7451

FHL

Transurethral adenoma removal

1.4

6.4

251

1209

S20

ICPC

Corn/callosity

1.4

6.3

314

1572

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

0.5

6.3

943

N95

ICD-10 Finland

Menopausal and other perimenopausal disorders

0.5

6.3

707

D07BC01

ATC

betamethasone and antiseptics; topical

1.1

6.3

1689

10158

SAD02, ,

SPAT

6.1

6.3

180

Kela drug reimbursment

Interferon alfa

0.2

6.3

247

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

1.3

6.3

476

2534

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.7

6.3

215

2101

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.3

6.3

397

2062

B01AF02

ATC

apixaban; oral

1.1

6.3

2667

16512

S01EE01

ATC

latanoprost; ophthalmic

1.2

6.3

1274

7505

H43.8

ICD-10 Finland

Other disorders of vitreous body

0.8

6.3

960

7755

NA3BG, ,

SPAT

0.6

6.3

112

1251

L04AX01

ATC

azathioprine; systemic

0.7

6.3

250

2378

G40.89

ICD-10 Finland

Other epilepsy

2.2

6.3

165

NH3AA, ,

SPAT

0.5

6.3

832

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

+∞

6.3

F028, G318,

ICD-10 Finland

+∞

6.3

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

0.2

6.3

209

P01AB01

ATC

metronidazole; oral, rectal

0.9

6.2

4865

35517

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

6.2

9450

61966

A96

ICPC

Death

1.7

6.2

103

406

QAB00

NOMESCO Finland

Suture of skin of head or neck

1.5

6.2

161

712

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

0.5

6.2

693

B05DA

ATC

Isotonic solutions

0.3

6.2

336

M76.0

ICD-10 Finland

Gluteal tendinitis

0.6

6.2

1059

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

0.5

6.2

838

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.6

6.2

116

1280

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

0.2

6.2

219

A10BH01

ATC

sitagliptin; oral

1.2

6.2

1601

9610

K07

ICPC

Swollen ankles/oedema

1.2

6.2

852

4855

F0234, G20,

ICD-10 Finland

17.1

6.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.1

6.1

4779

30500

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

0.8

6.1

553

4705

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.7

6.1

121

501

T19.1

ICD-10 Finland

Foreign body in bladder

3.8

6.1

SPAT1062

SPAT

Lung clearance therapy

2.1

6.1

203

A10BJ02

ATC

liraglutide; parenteral

0.6

6.1

119

1302

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

0.1

6.1

146

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.1

6.1

1598

9597

P71

ICPC

Organic psychosis other

5.8

6.1

212

Kela drug reimbursment

Gout

0.7

6.1

214

2080

C01BD01

ATC

amiodarone; systemic

0.7

6.1

310

2839

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

2.1

6.1

185

A57

ICPC

General and Unspecified, Physical medicine/rehabilitation

3.2

6.1

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

0.6

6.1

124

1343

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

2.8

6.1

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

0.8

6.1

501

4307

S79.9

ICD-10 Finland

Unspecified injury of hip and thigh

1.6

6.1

129

544

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

0.4

6.1

487

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

2.1

6.1

199

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.6

6.1

134

571

F01.84

ICD-10 Finland

Other specified vascular dementia other mixed symptoms of mixed type

4.1

6.1

SPAT1142

SPAT

Minor procedure on teeth, gums, mouth and pharynx

2.6

6.1

C10AA03

ATC

pravastatin; oral

1.2

6.1

1358

8065

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.1

6.1

4220

26798

C10BA06

ATC

rosuvastatin and ezetimibe; oral

0.5

6.1

677

AA3AD

NOMESCO Finland

CT of face

1.8

6.0

369

L90

ICPC

Osteoarthrosis of knee

0.8

6.0

779

6388

H81

ICPC

Excessive ear wax

1.1

6.0

3234

20278

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

0.2

6.0

307

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

996

1661

4.26

323.01

1.3

1.4

419.70

2746.28

e6/l

1.11

796

1376

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1006

1694

4.22

322.40

1.2

3.83

3.86

mmol/l

0.40

949

1581

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

995

1661

4.25

322.35

1.2

1.4

12.46

34.95

e6/l

1.41

760

1300

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6064

24079

2.02

307.65

2.7

3.2

2.45

2.47

mmol/l

21.21

5324

20738

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1120

1957

4.08

307.65

1.2

1.3

480.77

603.08

mg/l

5.93

1030

1866

(3019309) Folate [Moles/volume] in Red Blood Cells

8208

26987

2.80

307.65

1.9

1.8

1175.56

1152.09

nmol/l

1.32

6092

19643

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1053

422

17.92

307.65

1.0

384.98

284.43

ng/l

4.72

772

258

(3021960) Folate [Moles/volume] in Serum or Plasma

8549

31002

2.52

307.65

1.7

1.6

20.46

20.38

nmol/l

0.13

7245

25886

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6588

26832

2.00

307.65

1.8

1.7

4734391.58

31515562.63

pmol/l

8.38

5281

21028

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1067

418

18.34

307.65

1.0

51.75

34.08

ng/l

18.52

773

246

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11647

53228

2.15

307.65

2.4

2.1

91.81

93.37

pmol/l

2.72

6141

27107

(3015377) Calcium [Moles/volume] in Serum or Plasma

9003

41075

1.89

307.65

2.5

3.4

2.35

mmol/l

0.66

7604

34789

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1067

416

18.43

307.65

1.0

585.75

808.85

ng/l

17.71

763

238

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12012

63851

1.69

265.11

5.1

6.9

1.22

1.21

mmol/l

44.50

9954

53478

(3044290) Cell count panel - Cerebral spinal fluid

879

1575

3.94

259.39

1.2

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9026

45003

1.66

247.77

2.1

2.2

77.82

80.98

nmol/l

18.20

7591

38572

(3024561) Albumin [Mass/volume] in Serum or Plasma

10440

54324

1.64

239.37

3.6

4.7

34.82

34.21

g/l

22.85

9336

49866

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10905

58100

1.60

218.91

4.6

6.1

1.22

1.21

mmol/l

23.90

9598

52133

(3031040) Bacteria [#/volume] in Urine by Automated count

13725

77888

1.62

205.30

6.0

5.3

2850.46

1245.49

e6/l

2.25

349

1210

(3026008) Bacteria identified in Urine by Culture

8281

42462

1.56

183.97

3.8

3.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

581

1045

3.88

170.00

3.5

3.9

332.51

333.42

umol/l

0.05

471

868

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4871

22491

1.63

164.44

1.9

—

(3018418) pH of Serum or Plasma

7383

37937

1.52

154.27

3.0

4.2

7.40

1.17

1233

7290

(3023410) Appearance of Cerebral spinal fluid

443

696

4.42

153.69

1.2

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

15570

94627

1.52

128.33

5.0

2.03

2.11

mu/l

4.04

13799

83509

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9020

49498

1.44

127.16

4.5

4.4

54.93

83.17

ng/l

1.72

7317

39501

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13107

77061

1.45

126.82

3.8

4.1

15.27

15.20

pmol/l

2.41

11383

67585

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3412

15407

1.62

120.92

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3421

15504

1.61

119.27

1.9

1.8

—

(3023368) Bacteria identified in Blood by Culture

7146

37990

1.44

116.37

3.8

4.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7164

38507

1.42

107.39

2.3

2.2

252.29

212.70

u/l

3.08

6660

35638

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7955

44147

1.38

95.40

2.4

2.1

—

(3019150) Specific gravity of Urine by Refractometry

4715

24002

1.44

92.25

5.2

4.8

1.02

kg/l

0.65

769

3954

(40768804) Tissue Pathology biopsy report

5208

45426

0.71

90.08

2.2

2.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

13048

78706

1.36

89.48

5.2

4.9

—

(3016018) Differential panel - Cerebral spinal fluid

395

854

3.20

88.32

1.2

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6282

33847

1.39

88.29

2.3

2.4

3.02

3.16

mg/l

4.38

5106

28537

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16493

103717

1.44

85.89

18.9

18.6

29.54

27.51

mg/l

9.70

14016

85835

(3013826) Glucose [Moles/volume] in Serum or Plasma

11744

70762

1.31

72.48

4.5

4.9

7.02

6.89

mmol/l

6.51

11105

66650

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1799

7840

1.62

70.75

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1951

8757

1.58

67.75

1.8

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

9274

54591

1.29

64.89

4.7

4.3

0.00

estimate

0.48

1758

11358

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7173

40856

1.31

64.05

5.1

4.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

17088

109698

1.39

60.49

23.2

22.4

139.70

139.50

mmol/l

15.74

16540

106675

(3023103) Potassium [Moles/volume] in Serum or Plasma

17095

109813

1.38

59.52

23.2

22.6

4.00

4.01

mmol/l

2.42

16518

106630

(4035726) Immunohistochemistry procedure

986

11294

0.58

59.40

1.3

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

196

345

3.91

59.12

1.2

40.38

60.62

—

(3009261) Glucose [Presence] in Urine by Test strip

9284

55219

1.27

56.82

4.7

4.3

0.00

estimate

1.34

1541

10212

(3015736) pH of Urine

7519

43773

1.27

53.84

4.3

4.0

5.96

5.83

1.13

156

1231

(3021601) Nitrite [Presence] in Urine by Test strip

9134

54529

1.26

52.60

6.0

5.7

0.00

estimate

0.50

1555

10381

(40761511) CBC panel - Blood by Automated count

16299

104414

1.32

52.41

18.6

18.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

10530

63934

1.26

52.34

20.1

20.5

1.38

1.41

inr

1.31

2712

17826

(3029937) Albumin [Presence] in Urine by Test strip

5381

30280

1.29

49.42

5.0

4.7

0.00

estimate

1.56

1452

9817

(3010813) Leukocytes [#/volume] in Blood

17154

110947

1.34

49.20

27.6

27.7

7.09

6.98

e9/l

4.48

16425

106651

(3009542) Hematocrit [Volume Fraction] of Blood

17146

110905

1.34

48.95

27.6

27.7

38.23

38.98

31.64

15144

101458

(3007461) Platelets [#/volume] in Blood

17146

110923

1.34

48.70

27.6

27.7

235.27

238.79

e9/l

9.39

16491

107109

(3035941) MCH [Entitic mass]

17146

110933

1.34

48.55

27.5

30.45

30.43

0.45

16651

108598

(3026361) Erythrocytes [#/volume] in Blood

17147

110941

1.34

48.55

27.6

27.7

4.28

4.35

e12/l

70.94

16408

106597

(3024731) MCV [Entitic volume]

17146

110939

1.34

48.47

27.5

27.6

92.00

91.89

2.23

16655

108605

(3000963) Hemoglobin [Mass/volume] in Blood

17147

110951

1.34

48.40

27.8

27.9

129.23

131.53

g/l

73.96

16640

108637

(3013707) Erythrocyte sedimentation rate by Westergren method

12933

80763

1.25

48.28

3.9

4.5

14.68

15.43

mm/h

5.55

11531

73125

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1519

14983

0.67

46.68

1.2

16.94

16.64

u/ml

0.04

448

4838

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13886

87778

1.25

44.13

5.7

8.0

79.59

82.07

u/l

5.15

12670

82053

(3006270) Folate [Moles/volume] in Blood

352

1058

2.30

42.26

1.3

1.2

317.69

306.93

nmol/l

0.40

285

777

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1691

15984

0.70

40.80

1.2

1.3

48.99

42.53

iu/ml

0.70

519

4863

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

132

235

3.86

39.38

1.2

35.43

23.20

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

908

9646

0.63

39.31

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

252

674

2.57

38.84

2.4

2.3

—

(3012516) Albumin [Mass/volume] in Urine

4904

39596

0.80

37.77

2.9

3.3

470.87

386.26

mg/l

0.58

3167

25186

(3020682) Albumin/Creatinine [Ratio] in Urine

5253

41922

0.81

35.82

3.4

3.8

9.20

9.80

mg/mmol

0.40

3288

26148

(3009508) Creatinine [Moles/volume] in Urine

4966

39768

0.81

34.69

2.8

3.2

6.98

6.86

mmol/l

1.19

3959

32307

(3037522) Nuclear Ab [Titer] in Serum

1294

12474

0.69

34.43

1.2

1.3

537.73

533.31

titre

0.03

282

2943

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16656

108443

1.26

34.15

21.9

22.5

84.57

85.52

umol/l

2.77

16650

108381

(3019225) pH of Specimen

2554

13631

1.32

32.98

3.8

4.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

934

4176

1.55

32.32

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3395

28130

0.79

31.64

1.5

1.6

1.22

1.28

mmol/l

6.27

2795

22797

(3003338) MCHC [Mass/volume]

12436

78860

1.20

31.25

26.1

25.4

330.44

330.69

g/l

2.20

12201

78038

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1323

6414

1.44

30.83

1.5

1.6

1.63

1.65

0.42

1079

5134

(3019832) Treponema pallidum Ab [Presence] in Serum

535

2108

1.75

30.30

1.2

1.3

—

(3002256) Pathology report gross observation

1777

15877

0.74

29.31

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

945

9377

0.67

29.14

1.5

—

(3014271) Vancomycin [Susceptibility]

294

972

2.08

28.14

3.1

—

(1761868) Lipid panel - Serum or Plasma

3089

25575

0.79

28.05

3.4

3.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4628

27034

1.22

27.41

4.5

4.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

253

802

2.17

26.96

1.1

—

23.45

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2391

13000

1.29

26.51

2.4

2.5

5.41

6.54

ug/l

2.88

1782

11124

(3000492) Spirometry study

822

8206

0.67

26.06

1.4

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1777

15591

0.76

25.48

2.9

3.9

12.97

25.36

ug/l

2.01

1442

13071

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

211

641

2.26

24.93

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

1112

10401

0.72

24.41

3.1

3.8

1.06

0.95

0.41

360

3953

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

824

8121

0.68

24.38

1.4

—

(3003694) ABO and Rh group [Type] in Blood

3190

25971

0.81

24.27

1.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3950

31461

0.82

24.09

2.4

3.0

7968.95

6534.62

umol/l

0.86

3151

26396

(3002179) Metamyelocytes/100 leukocytes in Blood

989

9397

0.70

23.83

3.0

3.7

0.76

0.68

0.27

292

3388

(40761535) Cells panel - Urine sediment

2025

10920

1.30

23.76

3.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2820

15873

1.25

23.24

9.5

8.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

1054

9866

0.72

23.20

3.1

3.8

0.13

0.10

0.46

306

3452

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

432

4830

0.60

23.04

2.4

4.1

124.20

90.04

u/ml

0.43

406

4639

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4422

26087

1.20

22.97

4.3

230.75

459.08

ng/l

5.07

3967

22924

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

220

706

2.14

22.83

1.2

2.10

2.31

mmol/l

1.15

205

644

(3028026) IgM [Mass/volume] in Serum or Plasma

595

6165

0.65

22.65

1.8

1.9

1.84

1.40

g/l

1.33

493

5462

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

271

958

1.95

21.72

1.3

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2030

11074

1.28

21.68

2.9

4.0

1.23

mmol/l

2.44

1636

9600

(3041096) Erythrocytes [Presence] in Urine by Automated

4607

27407

1.19

21.60

4.3

4.1

—

(4200892) Spirometry reversibility

912

8629

0.71

21.38

1.4

—

(3018095) Leukocytes [#/volume] in Urine

7167

44286

1.16

20.99

4.1

4.0

147.10

127.70

e6/l

0.64

5246

32561

(3017143) Hepatitis C virus Ab [Presence] in Serum

807

7772

0.70

20.97

1.4

1.5

—

(3025159) Blasts/100 leukocytes in Blood

989

9205

0.72

20.96

3.1

3.9

0.51

0.32

0.24

250

2854

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

981

9125

0.72

20.70

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7106

43937

1.16

20.50

2.6

3.0

142.37

163.47

ug/l

9.64

6137

39271

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1081

5448

1.38

20.06

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

207

2723

0.51

19.88

1.5

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1831

9964

1.28

19.88

1.5

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1153

5885

1.36

19.76

1.9

2.0

—

(3022621) pH of Urine by Test strip

1501

7981

1.31

19.44

3.8

3.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1637

8902

1.28

17.81

5.1

6.7

24.47

24.59

mmol/l

0.62

1562

8480

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16443

108522

1.18

17.79

9.9

12.0

22.04

24.05

u/l

12.49

15400

103330

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

110

1734

0.43

17.74

1.4

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

942

4737

1.38

17.72

1.9

2.2

851.57

537.26

ug/l

0.72

876

4478

(3002582) Erythrocytes [#/volume] in Urine

6373

39428

1.15

17.46

3.6

3.5

122.01

115.07

e6/l

0.10

4982

30726

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9237

58742

1.14

16.50

2.9

3.2

48.38

58.17

u/l

19.06

8126

52507

(3022145) Colonoscopy Study observation

1477

12595

0.79

16.49

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

2006

0.49

16.34

3.2

4.1

313.12

1854.72

iu/ml

1.13

309

(3021589) Normoblasts [#/volume] in Blood

6428

48085

0.87

16.30

9.8

10.9

0.00

e9/l

1.35

5228

39029

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

268

3088

0.59

16.21

1.8

3.1

168.36

756.37

u/ml

3.52

230

2800

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

309

3435

0.61

16.16

1.4

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

496

4978

0.67

16.13

1.2

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

842

7715

0.73

16.06

2.5

2.8

10.72

10.68

g/l

0.07

717

7005

(3005322) IgE [Units/volume] in Serum or Plasma

474

4766

0.67

15.57

1.2

1.3

259.75

255.94

u/ml

0.04

418

4318

(3013139) Helicobacter pylori Ag [Presence] in Stool

758

7005

0.73

15.29

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

1982

16237

0.82

15.25

1.2

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

342

3656

0.63

15.11

1.6

1.4

25.54

16.06

iu/ml

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

278

3096

0.61

14.69

2.0

2.1

3.65

g/l

0.01

261

2937

(3000850) Epithelial cells [#/volume] in Urine

4589

28017

1.15

14.60

2.7

5.39

4.96

e6/l

1.69

4122

25001

(4281824) Cell count and differential, peritoneal fluid

1263

0.40

14.35

1.1

1.2

—

(36304419) Bacteria [Presence] in Urine

5552

34417

1.14

14.07

3.5

3.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

234

2688

0.59

14.04

2.2

201.87

211.03

0.90

213

2534

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1038

0.35

13.96

1.5

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

588

5572

0.71

13.89

1.4

1.5

44.69

17.48

u/ml

0.97

127

(3018572) Chloride [Moles/volume] in Blood

607

2961

1.41

13.73

4.5

6.8

105.12

104.81

mmol/l

0.79

557

2657

(3039000) Anion gap in Blood

607

2961

1.41

13.73

4.5

6.8

11.32

11.26

mmol/l

0.15

557

2657

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

257

2859

0.61

13.55

1.8

2.0

91.61

87.23

2.88

242

2736

(21494755) Public health laboratory ask at order entry panel

1342

0.44

13.39

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

539

5149

0.71

13.37

2.2

3.2

257.19

2299.55

u/ml

2.91

426

4397

(3047181) Lactate [Moles/volume] in Blood

813

4187

1.34

13.19

4.3

5.9

1.39

1.34

mmol/l

0.57

737

3722

(3020779) Urea [Moles/volume] in Serum or Plasma

1556

12878

0.81

13.14

3.9

6.2

11.07

11.66

mmol/l

2.34

1405

12067

(3027945) Reticulocytes/100 erythrocytes in Blood

2914

17337

1.17

12.83

2.0

2.4

1.73

1.78

1.65

2390

15133

(3007164) IgA [Mass/volume] in Serum or Plasma

2122

16995

0.84

12.69

1.4

1.5

2.80

2.71

g/l

0.68

1007

9173

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5966

37366

1.13

12.54

2.3

2.6

71.35

60.89

u/l

0.35

5413

34112

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

438

4281

0.69

12.41

1.6

148.00

243.67

titre

1.46

206

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

449

4369

0.70

12.41

1.6

1.7

37.97

38.04

u/l

0.02

364

3654

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7197

45630

1.12

12.21

5.0

5.9

5.04

4.52

ug/l

0.23

6116

40063

(4034850) Laboratory test

671

3403

1.36

12.07

13.8

12.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

301

2.25

11.95

1.5

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

272

2889

0.64

11.76

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2139

17001

0.84

11.65

2.8

3.9

247.66

249.82

u/l

0.25

1918

15967

(40768793) Breast Pathology biopsy report

210

2361

0.60

11.64

1.2

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

132

455

1.99

11.62

1.1

37.26

46.13

mg/l

2.05

105

387

(3052592) Norovirus Ag [Presence] in Stool

285

2.26

11.44

1.2

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

504

2463

1.41

11.36

1.6

2.2

26.52

33.43

umol/l

9.52

414

2123

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

223

2453

0.62

11.29

1.2

3.23

4.62

u/ml

1.14

413

(3024980) IgG subclass 4 [Mass/volume] in Serum

113

1492

0.51

11.20

1.5

1.6

0.66

0.89

g/l

1.56

1109

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

1529

0.52

11.01

1.6

2.1

573.71

1750.85

u/ml

—

111

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

222

2429

0.62

10.99

1.2

3.97

5.17

u/ml

0.25

277

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

155

1853

0.57

10.94

1.4

1.5

226.20

245.13

pmol/l

0.11

148

1800

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

263

2767

0.64

10.91

1.8

12.01

12.31

mg/l

0.20

231

2508

(3015171) Extractable nuclear Ab [Units/volume] in Serum

362

3574

0.69

10.89

1.2

0.45

1.01

u/ml

1.81

351

(3020191) Ethanol [Moles/volume] in Serum or Plasma

149

548

1.86

10.89

1.3

1.2

0.84

1.05

promille

1.03

120

400

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

135

1673

0.55

10.85

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7412

54088

0.90

10.84

2.5

2.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

243

2595

0.64

10.81

1.2

47.19

40.54

u/ml

0.10

140

(4094501) Cardiovascular stress test using bicycle ergometer

265

2775

0.65

10.76

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

223

2401

0.63

10.32

1.1

1.2

98.75

141.53

titre

0.92

176

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1082

5977

1.25

10.32

3.8

5.0

1.65

1.56

1.21

1025

5630

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

189

2112

0.61

10.27

1.2

2.04

6.48

u/ml

1.63

166

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

593

5349

0.75

10.21

2.8

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

171

1942

0.60

9.95

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

537

2717

1.36

9.88

3.9

3.8

31.35

29.93

mg/l

0.35

376

1761

(3007930) Methemoglobin/Hemoglobin.total in Blood

1065

5903

1.25

9.86

3.8

5.0

0.90

0.86

2.84

1009

5551

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

120

425

1.93

9.86

1.1

270.00

326.76

mg/l

2.26

100

371

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2292

13649

1.17

9.84

3.1

233.18

266.65

ng/l

2.86

2099

12576

(3026782) Osmolality of Urine

4367

27201

1.12

9.60

3.1

3.2

551.19

536.64

mosm/kgh2o

4.75

3713

23235

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

142

538

1.81

9.52

1.2

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

745

3973

1.29

9.51

3.7

3.1

0.78

0.82

nmol/l

1.49

569

3100

(3030467) Casts [#/volume] in Urine by Automated count

5743

36340

1.11

9.49

3.4

0.53

0.50

e6/l

0.53

4502

28260

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

102

346

2.02

9.47

3.2

2.7

27.96

29.36

umol/l

0.61

256

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1226

0.51

9.47

1.0

1.1

1.60

1.56

g/l

0.36

1078

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

110

1379

0.54

9.28

1.3

115.63

123.93

u/ml

0.38

311

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

238

2461

0.66

9.17

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

136

1599

0.58

9.11

1.3

—

(40768443) Skin Pathology biopsy report

642

5637

0.77

9.08

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

292

2888

0.69

8.95

1.4

1.5

0.23

g/l

0.32

267

2707

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

302

2964

0.69

8.88

1.4

1.5

1.14

1.16

g/l

0.38

279

2791

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

147

2.56

8.86

1.0

1.3

23.25

51.07

3.02

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

609

3197

1.31

8.78

1.3

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

159

1778

0.61

8.74

2.9

3.5

29.23

44.16

u/ml

1.74

150

1728

(46235355) HIV 1 and 2 tests - Meaningful Use set

1078

8888

0.82

8.73

1.3

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

345

1657

1.43

8.68

7.9

12.0

7.79

7.38

mmol/l

1.06

271

1365

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

110

396

1.90

8.68

2.4

2.1

60.42

52.27

umol/l

1.60

315

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

524

1.78

8.67

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

608

3197

1.31

8.66

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1152

9423

0.83

8.59

2.7

2.9

59.13

57.05

ml/min/173m2

1.34

487

4235

(3045142) Bone marrow Pathology biopsy report

134

1555

0.59

8.56

1.2

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

364

1775

1.41

8.43

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

13505

95133

0.91

8.22

3.9

4.4

1.20

1.25

mmol/l

16.10

11533

83055

(40768795) Lymph node Pathology biopsy report

1177

0.54

8.16

1.1

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

776

4244

1.26

8.14

3.3

4.1

3.91

3.92

mmol/l

0.11

771

4200

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

195

2046

0.65

8.12

1.5

1.8

15.47

24.35

ug/l

6.14

189

1990

(40768800) Prostate Pathology biopsy report

332

3154

0.71

8.11

1.1

1.2

—

(3044889) 12 lead EKG panel

11741

77215

1.09

8.10

4.8

4.6

—

(40768441) Liver Pathology biopsy report

720

0.42

8.08

1.0

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

242

2428

0.68

8.06

3.4

2.06

1.54

0.91

190

2115

(3000494) Fungus identified in Specimen by Culture

1625

12825

0.85

8.00

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

253

2513

0.68

7.99

1.3

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

156

1709

0.62

7.91

1.2

50.04

45.16

u/ml

0.12

183

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

165

2.36

7.84

2.2

2.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

7170

51832

0.92

7.71

4.8

6.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5690

36296

1.10

7.67

4.6

5.1

21.74

22.46

3.08

2929

20271

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7055

45464

1.09

7.59

2.9

3.3

1947.68

1900.45

ng/l

0.33

5969

39773

(3042631) Mycobacterium sp identified in Specimen

225

2252

0.68

7.43

2.4

2.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

165

2.32

7.43

2.2

2.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1834

10967

1.16

7.42

2.5

3.1

4.27

4.41

kpa

2.01

1761

10566

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

129

1453

0.60

7.39

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

520

1.71

7.37

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

365

1.86

7.35

1.5

107.83

91.30

umol/l

0.39

209

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

654

5573

0.80

7.28

2.1

2.7

0.38

0.35

u/ml

1.23

369

3211

(3024666) Lithium [Moles/volume] in Serum or Plasma

195

2.18

7.10

15.9

11.4

0.69

0.64

mmol/l

0.55

177

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

213

972

1.50

7.05

1.2

1.4

—

(3008898) HLA-B27 [Presence]

148

1595

0.63

7.04

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

216

991

1.49

6.97

1.2

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

314

2932

0.73

6.96

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

451

3984

0.77

6.78

1.5

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3597

22552

1.11

6.76

3.0

1.46

1.35

e6/l

0.38

2079

13320

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

666

0.45

6.70

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

310

2882

0.73

6.69

2.2

2.6

1.70

1.84

mg/l

2.22

255

2546

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14025

98331

0.92

6.69

4.3

4.9

1.46

1.45

mmol/l

2.69

12155

86854

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

395

0.29

6.67

1.0

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

146

1558

0.64

6.67

1.3

0.66

1.76

nmol/l

0.86

134

1481

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

147

1566

0.64

6.66

1.3

0.28

0.31

nmol/l

0.07

126

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3360

21014

1.11

6.61

3.2

2.69

2.54

e6/l

0.34

1874

11878

(3018405) Lactate [Moles/volume] in Arterial blood

878

4993

1.21

6.46

3.1

3.9

1.40

1.41

mmol/l

0.09

862

4896

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2355

17864

0.89

6.45

3.4

5.3

1.02

1.04

mmol/l

4.75

2058

16306

(3023419) Bacteria identified in Sputum by Culture

232

2245

0.70

6.42

2.1

2.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

250

1.97

6.42

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

159

1652

0.65

6.42

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

275

2585

0.72

6.39

1.3

1.5

30.45

31.49

g/l

0.78

244

2307

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

940

7613

0.84

6.34

5.7

7.6

24.21

24.39

mmol/l

0.92

880

7262

(3019060) Gas panel - Arterial blood

1628

9766

1.15

6.32

3.6

4.5

—

(3042936) Bacteria identified in Isolate by Culture

2370

17949

0.89

6.31

1.9

2.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

955

0.56

6.23

1.2

1.4

2.76

2.95

g/l

0.46

658

(3024139) IgG subclass 3 [Mass/volume] in Serum

954

0.56

6.20

1.2

1.4

0.39

0.45

g/l

0.76

657

(3027135) IgG subclass 1 [Mass/volume] in Serum

954

0.56

6.20

1.2

1.4

6.67

7.29

g/l

0.74

655

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

553

4708

0.80

6.16

1.1

89.15

124.24

iu/ml

1.41

173

1509

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

124

1345

0.63

6.13

1.0

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

308

2820

0.74

6.05

1.5

37.10

4.82

iu/ml

1.06

708

(3039162) Centromere protein B Ab [Units/volume] in Serum

103

1159

0.61

5.97

1.2

56.27

60.70

u/ml

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

272

1.89

5.94

1.1

—

(4062490) Immunoglobulin typing, IgG

949

0.57

5.91

1.2

1.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.87

5.89

1.1

1.5

48.33

43.24

0.18

(3008116) Ketones [Moles/volume] in Urine by Test strip

211

2.01

5.88

1.2

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

546

2986

1.26

5.85

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

269

1.88

5.83

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

107

435

1.68

5.82

1.5

1.9

53.00

57.62

ug/l

0.38

102

426

(3037692) Legionella sp identified in Specimen by Organism specific culture

476

0.40

5.78

1.4

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

167

1678

0.68

5.74

1.2

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

9058

64380

0.93

5.71

6.2

8.8

4.57

4.37

e9/l

9.11

7758

55418

(3014765) Yersinia sp identified in Stool by Organism specific culture

550

3020

1.25

5.70

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

577

0.46

5.66

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

814

0.54

5.66

1.1

1.2

197.69

130.21

titre

0.31

144

(42529406) Shigella sp [Presence] in Stool by Culture

551

3031

1.25

5.62

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.05

5.62

1.1

1.5

12.14

13.63

0.12

(21494434) Karyotype in Bone marrow

125

1316

0.65

5.45

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15204

101720

1.08

5.45

5.0

5.4

6.17

6.13

mmol/l

2.83

13128

89363

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

113

1214

0.63

5.41

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

102

419

1.67

5.37

1.1

—

(3022096) Basophils/100 leukocytes in Blood

7075

50658

0.93

5.37

4.7

5.9

0.62

0.64

1.72

6364

46619

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

130

1352

0.65

5.35

1.1

1.3

236.74

271.09

pmol/l

1.06

106

1135

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

592

0.48

5.34

2.0

2.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

101

1109

0.62

5.33

1.1

1.2

5.00

4.67

u/ml

0.04

380

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

208

1981

0.71

5.33

1.3

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

937

0.59

5.30

1.1

1.2

48.00

37.20

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

117

1241

0.64

5.30

1.1

1.2

270.94

290.19

u/ml

0.33

731

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

876

0.58

5.30

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

880

0.58

5.20

1.1

1.2

2.80

3.47

u/ml

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

713

0.54

5.20

1.9

2.3

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.13

5.17

1.1

1.4

1.27

1.58

0.10

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1049

0.62

5.16

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

119

1248

0.65

5.12

2.4

3.7

30.01

59.49

u/ml

4.63

113

1219

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

960

0.60

5.08

1.0

1.1

113.82

115.26

0.17

826

(3002385) Erythrocyte distribution width [Ratio]

12919

85999

1.07

5.07

22.2

22.1

15.59

15.61

0.07

12614

84269

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

398

0.39

5.01

1.0

1.8

266664.00

39775.33

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

138

1397

0.67

5.00

1.1

1.2

62.20

61.48

u/l

0.04

112

1250

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

407

1.65

4.99

1.7

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

407

1.65

4.99

1.7

2.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4060

29625

0.92

4.98

2.2

2.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

168

2.04

4.97

1.9

2.4

142.23

126.76

nmol/l

0.50

145

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

191

1821

0.71

4.95

1.2

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1127

6708

1.16

4.93

3.6

4.4

45.35

46.43

0.81

1113

6626

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

424

0.42

4.92

1.5

1.8

4672.86

15056.02

e6/l

1.17

239

(40768806) Pleura Pathology biopsy report

211

1975

0.73

4.89

1.4

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

160

1567

0.70

4.86

3.5

3.6

—

(3025130) Human papilloma virus identified in Specimen

572

0.50

4.86

1.8

1.5

—

(3012441) Differential panel - Pleural fluid

210

1964

0.73

4.84

1.4

1.5

—

(3036489) Thrombin time

456

3854

0.80

4.84

1.6

1.8

21.40

22.16

1.15

405

3482

(3024891) Influenza virus A+B Ag [Presence] in Specimen

445

2435

1.25

4.82

1.2

—

(3011412) CD3 cells [#/volume] in Blood

928

0.61

4.78

2.3

1.9

1.13

1.06

e9/l

0.24

847

(3011985) Renin [Units/volume] in Plasma

146

1449

0.69

4.78

1.2

1.4

35.17

56.67

mu/l

1.93

119

1270

(3003181) Sodium [Moles/volume] in Urine

481

2662

1.24

4.72

1.3

64.64

61.15

mmol/l

1.23

389

2143

(3019069) Monocytes/100 leukocytes in Blood

7348

52371

0.94

4.70

5.1

6.2

8.86

8.95

1.45

6632

48253

(3028717) Thiamine [Mass/volume] in Blood

2.44

4.69

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

158

2.03

4.68

1.1

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

742

0.57

4.68

2.0

1.8

39.37

36.84

0.71

720

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

750

0.57

4.66

1.0

1.2

94.22

91.45

0.43

684

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

102

1081

0.64

4.66

1.6

1.8

4.45

4.54

mg/l

0.07

1015

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

198

0.28

4.64

13.5

12.5

6.29

5.21

mmol/l

—

198

(3006504) Eosinophils/100 leukocytes in Blood

7309

52083

0.94

4.63

4.8

5.9

2.80

2.82

0.41

6581

47948

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

276

1.76

4.61

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

478

0.47

4.60

1.5

1.9

503.76

3805.37

e6/l

1.05

330

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

138

1372

0.69

4.58

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

135

1347

0.68

4.57

1.1

1.3

—

(3008295) Osmolality of Serum or Plasma

243

1237

1.35

4.56

1.3

274.36

274.95

mosm/kgh2o

0.13

166

906

(3004775) Volume in Urine collected for unspecified duration

119

1214

0.67

4.53

2.0

2.2

629.36

665.09

0.40

764

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

638

0.55

4.52

1.2

1.1

0.28

1.05

u/ml

2.68

329

(3001604) Monocytes [#/volume] in Blood

7752

55102

0.94

4.51

4.5

5.5

0.62

0.63

e9/l

2.27

6536

46452

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

655

0.55

4.50

1.1

—

(40757373) Influenza virus identified in Isolate

253

1.78

4.50

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

367

1981

1.27

4.49

1.1

7.45

13.69

u/ml

—

(3006315) Basophils [#/volume] in Blood

7786

55329

0.94

4.48

4.5

5.6

0.04

e9/l

1.67

6567

46659

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

654

0.55

4.48

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

654

0.55

4.48

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

136

1348

0.69

4.46

1.4

1.3

—

nmol/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

651

0.56

4.42

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

651

0.56

4.42

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

461

0.47

4.41

2.8

2.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

162

1.98

4.40

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

650

0.56

4.39

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

196

1822

0.73

4.39

1.5

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

128

1277

0.68

4.36

1.2

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

854

0.61

4.33

3.0

3.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

157

1506

0.71

4.29

2.8

3.4

59.98

57.75

0.55

110

1238

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

404

3407

0.81

4.25

1.7

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14266

99397

0.94

4.24

4.4

5.0

4.32

4.38

mmol/l

9.37

12441

88641

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

294

1.70

4.23

1.4

1.2

102.31

131.69

nmol/l

1.01

211

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

173

1628

0.72

4.21

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

534

0.52

4.19

1.0

0.45

0.85

u/ml

0.59

223

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

316

1.67

4.17

1.4

16.78

16.92

pmol/l

0.06

254

(3030905) Polymorphonuclear cells [#/volume] in Blood

242

2164

0.76

4.16

2.4

3.2

4.76

4.43

e9/l

1.00

242

2158

(3042733) HLA Ab [Presence] in Serum

163

0.25

4.16

8.0

4.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

179

1670

0.73

4.13

1.2

1.4

6.24

6.40

mmol/l

0.33

159

1558

(3044640) Blood type and Crossmatch panel - Blood

5402

38767

0.94

4.12

2.3

2.6

—

(1002224) Polysomnography panel

205

1872

0.75

4.10

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

548

0.54

4.10

1.0

0.93

1.99

u/ml

0.83

246

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

548

0.54

4.10

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

188

1737

0.74

4.08

1.2

1.3

423.24

428.82

u/l

0.02

174

1647

(3023199) Leukocytes [#/volume] in Pleural fluid

254

2250

0.77

4.08

1.4

1.5

3505.87

2205.12

e6/l

0.65

187

1626

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

205

1869

0.75

4.06

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

277

1.70

4.06

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

229

2053

0.76

4.03

1.3

1.5

54508.68

65863.86

e6/l

0.31

142

1214

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

124

575

1.48

4.00

1.6

1.4

14.46

14.95

umol/l

0.26

114

535

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

248

1.74

3.98

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2873

21076

0.92

3.95

2.1

2.9

0.82

0.81

mmol/l

0.54

2538

19396

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

264

2316

0.78

3.94

1.3

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

7488

53127

0.94

3.94

5.0

6.1

24.54

25.42

8.84

6770

49046

(3039443) Prostate specific Ag panel - Serum or Plasma

111

1113

0.68

3.93

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

748

0.61

3.92

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

748

0.61

3.92

1.3

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

7358

52224

0.94

3.91

4.9

5.8

60.07

59.12

8.61

6651

48172

(3023520) Reticulocytes [#/volume] in Blood

2114

13257

1.10

3.91

2.0

2.5

65.24

67.91

e9/l

2.84

1611

10123

(3016750) Collection duration of Urine

837

0.64

3.85

1.9

2.0

494.69

498.92

min

0.10

580

(3009214) Lutropin [Units/volume] in Serum or Plasma

128

1245

0.70

3.84

1.4

1.3

10.81

12.57

u/l

0.79

983

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

667

0.59

3.84

2.2

1.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

232

2057

0.77

3.78

1.2

1.3

—

(3000991) Gas panel - Venous blood

1550

11679

0.90

3.78

4.7

7.0

—

(40765096) Chromosome analysis panel by Banding

407

0.49

3.77

1.2

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9466

62717

1.06

3.77

4.1

6.2

12.30

12.27

umol/l

0.08

8716

59451

(3010726) Horse dander IgE Ab [Units/volume] in Serum

416

0.49

3.76

1.1

1.0

0.27

0.47

u/ml

0.62

227

(3013115) Eosinophils [#/volume] in Blood

8038

56853

0.94

3.75

4.7

5.7

0.20

e9/l

0.19

6819

48569

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

378

0.47

3.74

1.1

1.4

107.17

148.84

pmol/l

1.23

378

(3016502) Oxygen saturation in Arterial blood

2316

14619

1.09

3.73

4.7

6.5

95.28

95.20

0.21

2217

14041

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3227

20659

1.08

3.70

1.7

1.9

29.56

30.22

7.03

3105

20043

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1690

10514

1.11

3.68

2.6

3.7

84.81

99.58

ng/l

10.82

1326

8753

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

245

1292

1.30

3.68

1.6

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

959

0.67

3.67

1.3

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2092

13164

1.10

3.61

4.9

7.0

120.29

119.22

g/l

1.64

2029

12812

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1499

9279

1.11

3.60

1.8

2.2

398.19

382.61

nmol/l

2.09

1290

8397

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

595

0.58

3.60

1.6

1.3

1.13

1.42

u/ml

0.15

351

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1189

7265

1.13

3.59

3.1

2.9

0.41

0.30

e6/l

1.12

1166

7154

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

696

0.62

3.57

1.0

1.1

27.25

28.34

u/l

0.07

599

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

108

1065

0.69

3.54

1.1

1.2

4.76

4.21

u/ml

0.19

471

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

694

0.62

3.53

1.0

1.1

84.02

88.39

u/l

0.23

602

(3048689) Calprotectin [Mass/mass] in Stool

1348

10193

0.90

3.53

1.8

2.0

170.96

167.61

ug/g

0.10

988

7767

(3004716) Salmonella sp identified in Stool by Organism specific culture

595

3467

1.18

3.52

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

173

0.32

3.52

1.1

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

199

1780

0.76

3.50

1.4

1.6

3.15

3.68

mg/l

0.36

151

1336

(21494814) CD8 cells/100 lymphocytes in Specimen

413

0.51

3.47

2.3

1.8

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

815

0.65

3.45

1.5

1.6

5.52

7.20

u/l

0.49

653

(3012544) pH of Venous blood

2188

13829

1.09

3.43

2.7

3.7

7.39

0.01

104

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

309

0.44

3.42

2.5

2.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

186

1673

0.76

3.42

1.8

2.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

121

1162

0.71

3.42

1.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

121

1162

0.71

3.42

1.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

121

1162

0.71

3.42

1.2

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

165

1509

0.75

3.41

1.6

55.50

49.05

nmol/l

1.95

157

1414

(3016038) Potassium [Moles/volume] in Urine

185

949

1.34

3.41

1.1

34.56

34.84

mmol/l

0.06

146

790

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

713

0.63

3.41

1.1

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

233

1237

1.29

3.36

2.3

2.2

2.80

2.37

u/field

0.37

429

(3021162) Amylase [Enzymatic activity/volume] in Specimen

218

0.34

3.36

1.9

2.5

685.45

1122.97

u/l

0.26

202

(40768446) Kidney Pathology biopsy report

315

0.45

3.33

1.1

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

101

996

0.69

3.33

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

890

0.67

3.32

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

856

6624

0.88

3.32

2.0

2.1

11.07

10.89

nmol/l

0.21

710

5562

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

265

2270

0.80

3.31

1.3

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

699

0.63

3.30

1.2

1.4

59.68

66.59

0.76

568

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2154

13631

1.09

3.29

4.4

3.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

154

0.31

3.28

1.3

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

215

0.35

3.27

1.0

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

553

0.59

3.26

1.1

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

553

0.59

3.26

1.1

1.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1091

6674

1.12

3.26

2.1

2.6

1.11

1.15

0.80

1083

6639

(3024932) HLA-DR beta [Type]

175

0.35

3.26

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

312

0.46

3.26

1.0

2.48

1.43

u/ml

—

129

(3003396) Base excess in Arterial blood by calculation

2564

16356

1.08

3.22

4.6

6.3

1.26

1.14

mmol/l

0.79

1951

13001

(3019198) Lymphocytes [#/volume] in Blood

7973

56237

0.95

3.20

4.7

5.7

1.76

1.88

e9/l

3.41

6836

48506

(3004119) Hemoglobin [Mass/volume] in Venous blood

1392

8641

1.11

3.20

2.7

3.3

127.97

125.95

g/l

3.05

1358

8422

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

396

1.50

3.16

1.1

32.02

460.62

ng/l

—

113

(3017817) Protein [Mass] in Urine collected for unspecified duration

140

1293

0.74

3.13

1.9

2.0

—

0.83

—

(3044242) Glucose [Moles/volume] in Arterial blood

141

704

1.37

3.13

1.7

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2109

13370

1.09

3.10

2.7

3.7

5.81

5.83

kpa

0.24

2037

12950

(3001893) Eosinophils/100 leukocytes in Pleural fluid

612

0.62

3.08

1.3

1.4

3.87

2.49

0.50

510

(3044007) Cell count panel - Peritoneal fluid

378

0.52

3.08

1.7

1.8

—

(3002032) Base excess in Venous blood by calculation

2105

13348

1.09

3.07

2.7

3.8

2.03

1.94

mmol/l

0.54

1791

11224

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1069

6558

1.12

3.06

2.1

2.6

0.67

0.66

0.70

1062

6529

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

711

0.65

3.06

1.1

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

693

0.65

3.04

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

137

0.30

3.02

1.5

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

197

1.70

2.97

1.8

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

190

1668

0.78

2.96

1.4

1.5

66.79

62.88

0.80

126

1039

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

504

0.60

2.96

1.6

1.9

927.14

1603.31

u/ml

2.11

489

(3045788) Cell count panel - Pleural fluid

196

1713

0.78

2.95

1.4

1.5

—

(3020891) Body temperature

919

5602

1.13

2.95

3.7

4.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

140

1279

0.75

2.94

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

223

0.40

2.93

1.6

1.31

2.30

ug/l

—

126

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

801

0.68

2.92

1.1

1.2

85.82

95.17

u/l

0.39

698

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

155

1392

0.76

2.89

1.2

1.3

23.40

11.99

u/l

2.09

137

1283

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

559

0.62

2.87

1.2

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

166

0.37

2.87

1.4

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

368

0.54

2.85

2.3

1.8

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.32

2.82

1.2

1.1

14.80

15.69

nmol/l

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

118

0.29

2.77

3.8

2.7

5.81

6.80

mg/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

268

2239

0.82

2.73

1.3

42.09

41.15

u/l

0.04

227

1916

(3034426) Prothrombin time (PT)

244

0.45

2.72

1.1

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.10

2.72

5.8

8.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

423

0.58

2.71

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

812

0.70

2.70

1.3

1.5

—

(3047189) Immunofixation for 24 hour Urine

723

0.68

2.70

1.3

1.7

—

(3012565) Volume of 24 hour Urine

616

0.65

2.69

2.0

2.1

1664.25

1784.53

0.37

514

(3014133) Dog dander IgE Ab [Units/volume] in Serum

334

0.53

2.68

1.0

1.06

1.95

u/ml

—

160

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

898

0.71

2.67

1.2

7.80

8.12

mmol/l

0.44

704

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

810

0.70

2.67

1.3

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14056

97525

0.95

2.66

18.0

18.2

69.00

69.84

ml/min/173m2

5.21

11460

81205

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

288

0.50

2.66

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

288

0.50

2.66

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

288

0.50

2.66

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

288

0.50

2.66

1.2

1.1

—

(3024471) HLA-A [Type]

183

0.37

2.64

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

522

0.63

2.64

2.9

2.5

42.00

36.42

1.19

322

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

141

1265

0.76

2.64

1.3

1.4

14.50

13.42

u/l

1.05

131

1215

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

419

1.44

2.62

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

562

0.64

2.61

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

141

1261

0.76

2.59

1.4

1.5

20.31

26.86

2.10

778

(3045414) Leukocytes [Presence] in Urine

830

5077

1.12

2.56

2.1

2.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

779

0.70

2.55

1.1

1.2

31.27

28.66

u/l

0.17

668

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

600

0.66

2.55

2.2

2.0

468.49

512.80

e6/l

0.33

508

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.94

2.52

11.6

10.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2543

16373

1.07

2.51

4.6

6.3

11.58

11.78

kpa

1.09

2405

15505

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2545

16387

1.07

2.51

4.6

6.3

4.95

5.07

kpa

7.45

2409

15528

(3034891) Synovial lining cells/100 cells in Synovial fluid

630

0.67

2.50

1.1

1.5

5.69

3.26

0.72

140

(3032057) Clostridioides difficile [Presence] in Stool

350

1.47

2.49

1.7

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

240

2006

0.82

2.49

1.3

0.82

0.81

nmol/l

0.08

195

1624

(1617658) Protocol used for examination of sentinel lymph nodes

791

0.71

2.49

1.1

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

436

1.41

2.46

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

137

1218

0.77

2.43

1.1

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

434

0.61

2.40

1.3

1.8

89.75

96.58

0.68

411

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

451

3555

0.86

2.39

1.3

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

583

0.67

2.39

1.7

1.5

5.28

6.44

u/l

1.65

470

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

243

2018

0.82

2.38

1.3

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

122

1.79

2.37

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

258

0.50

2.37

1.1

1.0

0.22

u/ml

—

103

(3022689) Creatine [Moles/volume] in Urine

328

0.56

2.34

1.2

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

345

1.45

2.30

1.1

1.05

1.09

u/l

0.45

169

(3035880) pH of Pleural fluid

115

1037

0.76

2.29

1.1

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1166

7308

1.10

2.29

2.9

3.6

25.33

25.12

mmol/l

1.35

1128

7110

(3033799) Differential panel - Peritoneal fluid

411

0.61

2.28

1.5

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

824

0.73

2.26

1.3

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

139

0.39

2.22

1.3

1.5

—

(3018133) Calcium [Moles/volume] in Urine

116

0.35

2.20

1.3

1.5

1.03

2.68

mmol/l

—

(3011288) Drugs identified in Urine by Screen method

221

1.55

2.18

2.2

1.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

178

1.61

2.17

3.0

2.8

0.50

0.52

u/field

0.05

178

(3023323) Follitropin [Units/volume] in Serum or Plasma

683

0.71

2.17

1.5

1.4

42.97

33.58

iu/l

1.07

571

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

762

0.73

2.16

2.2

41.30

137.26

ug/min

2.00

180

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

194

0.46

2.15

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.85

2.15

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

753

0.72

2.15

4.7

4.8

19.03

120.48

u/ml

3.90

221

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14594

98430

1.05

2.14

6.5

6.9

41.90

41.16

mmol/mol

13.49

12835

88303

(3010370) Gastrin [Moles/volume] in Serum or Plasma

174

0.43

2.12

2.9

1.5

64.64

57.29

pmol/l

0.14

131

(3026692) Albumin [Mass/volume] in Peritoneal fluid

343

0.60

2.11

1.3

1.4

13.90

15.13

g/l

0.29

269

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

967

6035

1.10

2.10

2.3

2.5

32.09

25.47

au/ml

0.52

284

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

435

0.64

2.10

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

246

0.53

2.08

3.6

2.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

125

0.38

2.08

6.9

4.8

20.00

50.08

ug/min

—

108

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

348

0.61

2.03

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

159

1353

0.80

2.03

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

200

1660

0.82

2.01

1.9

2.4

0.95

1.14

g/24h

0.52

783

(3033658) Prothrombin time (PT) actual/Normal

4206

29843

0.95

1.99

3.4

4.1

80.86

83.26

7.28

4086

29163

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

104

537

1.32

1.99

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

303

0.59

1.98

1.3

27.53

46.34

g/l

0.51

250

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

221

1.52

1.98

1.0

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

110

975

0.77

1.98

1.1

0.96

2.25

iu/ml

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

250

0.55

1.97

4.5

8.1

—

(3021788) Differential panel - Synovial fluid

296

2367

0.85

1.96

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

236

1923

0.84

1.96

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

528

4054

0.89

1.95

2.0

2.4

0.00

g/l

-0.00

447

3710

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

375

2944

0.87

1.95

1.3

1.5

—

(3025941) Bacteria identified in Stool by Culture

867

5408

1.10

1.93

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

100

0.34

1.92

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

300

0.59

1.92

2.5

2.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

274

0.57

1.92

1.1

1.4

1.63

1.55

g/l

0.58

274

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

239

0.54

1.92

1.1

1.3

116.38

114.73

0.11

207

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

823

0.75

1.91

1.1

1.2

222.89

194.87

miu/ml

0.18

173

(3006184) Hemoglobin [Mass/volume] in Capillary blood

552

3364

1.12

1.90

2.0

2.3

127.66

125.80

g/l

0.93

425

2436

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

375

0.64

1.90

1.3

40.90

34.65

u/l

0.36

308

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

586

0.71

1.89

1.0

292.60

291.39

mg/l

0.04

508

(3010838) Calcium [Moles/time] in 24 hour Urine

237

1920

0.84

1.86

1.5

1.7

4.17

4.47

mmol/24h

0.78

184

1598

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

182

0.49

1.84

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

437

0.67

1.83

1.4

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

163

903

1.24

1.82

7.4

12.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

105

0.39

1.81

1.3

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

144

1.61

1.81

1.2

1.1

16.02

16.69

umol/l

0.38

130

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.67

1.80

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

476

0.69

1.80

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

152

0.45

1.78

1.3

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

708

5319

0.91

1.78

2.5

3.2

49.66

79.30

mg/l

1.71

555

4326

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

707

5309

0.91

1.77

2.5

3.2

44.03

49.39

mg/l

0.43

558

4314

(3008536) Aspergillus sp Ab [Presence] in Serum

241

0.57

1.76

1.4

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

580

4399

0.90

1.76

1.9

2.3

0.02

0.05

g/l

1.11

484

3980

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.76

1.75

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.81

1.75

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

123

0.44

1.74

3.1

2.3

173.75

365.28

umol/l

—

115

(3002079) Sodium [Moles/time] in 24 hour Urine

415

0.67

1.73

1.1

1.2

136.76

155.69

mmol/24h

0.69

415

(3014007) Fractional oxyhemoglobin in Arterial blood

1197

8776

0.93

1.72

5.6

7.7

93.30

93.68

1.26

1190

8741

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

299

0.62

1.72

1.4

1.5

14.44

9.84

—

152

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.97

1.71

1.7

1.5

25.38

22.81

mmol/l

1.48

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

298

0.62

1.70

4.9

8.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

526

0.71

1.70

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

543

4123

0.90

1.70

2.0

2.4

0.00

g/l

0.07

450

3722

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

573

0.73

1.69

5.6

6.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

194

1582

0.84

1.67

3.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

147

1230

0.82

1.66

1.1

59.10

406.39

iu/ml

0.88

223

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

212

1219

1.19

1.66

1.9

1.6

30.96

25.83

u/ml

0.81

256

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

274

2170

0.86

1.66

2.3

3.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

132

0.47

1.65

1.2

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

271

1.41

1.65

1.7

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

251

1998

0.86

1.63

1.7

2.2

33.13

32.54

1.41

246

1983

(3002523) Influenza virus A Ag [Presence] in Specimen

474

0.71

1.63

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

243

0.59

1.61

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

105

908

0.79

1.61

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

487

3703

0.90

1.58

1.7

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

233

0.59

1.58

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

130

716

1.24

1.58

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

130

716

1.24

1.58

1.2

1.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

1.56

0.0

1.7

—

1.92

—

(3020393) Adenovirus Ag [Presence] in Stool

113

1.63

1.54

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

691

0.77

1.48

3.9

3.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

115

972

0.81

1.47

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.89

1.46

1.6

1.9

18.73

17.77

umol/l

0.10

(3036071) Salmonella sp Ab [Titer] in Serum

201

0.58

1.45

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

235

1858

0.86

1.44

5.3

6.0

12.82

12.41

mg/l

0.75

203

1677

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

509

0.74

1.43

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.42

1.43

1.8

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1864

12117

1.06

1.43

4.0

5.9

1.46

1.37

mmol/l

2.89

1810

11721

(44813793) Dust mix specific IgE antibody measurement

524

0.74

1.42

1.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

405

3088

0.89

1.42

1.3

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

101

549

1.26

1.41

1.3

1.2

1.05

1.16

nmol/l

0.52

419

(3036048) Francisella tularensis Ab [Titer] in Serum

199

0.58

1.40

1.1

1.2

—

1484.44

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

186

1492

0.85

1.38

1.3

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1001

6389

1.07

1.38

2.5

3.9

24.28

24.13

mmol/l

0.77

963

6199

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

695

5151

0.92

1.37

2.5

3.2

2.62

5.01

ratio

0.86

363

(40760888) Immunoglobulin light chains.free panel - Serum

528

3962

0.91

1.37

2.6

3.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1082

7884

0.93

1.37

4.4

6.0

24.74

24.83

mmol/l

0.31

1067

7791

(3011648) Oxygen content in Venous blood

105

887

0.81

1.36

1.3

1.7

10.38

10.66

0.26

105

887

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

1.35

0.0

1.0

—

0.10

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2169

15475

0.95

1.33

4.6

5.1

34.62

33.79

2.61

1322

9948

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

229

0.63

1.32

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

311

0.68

1.31

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

417

3158

0.90

1.31

1.5

1.6

20957.31

14927.84

e6/l

1.10

299

2256

(3020911) Cortisol [Moles/time] in 24 hour Urine

294

0.67

1.30

1.4

77.41

168.34

nmol/24h

1.38

294

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

251

1956

0.88

1.28

1.2

1.4

—

(40761536) Microorganisms panel - Urine sediment

1511

9801

1.06

1.28

4.7

4.6

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.41

1.28

1.0

1.4

—

27521.60

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1819

13015

0.95

1.26

2.1

2.6

8.83

9.95

umol/l

1.35

1511

11340

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

424

1.27

1.25

5.4

5.2

58.73

72.79

3.36

336

(3000093) Morphology [Interpretation] in Blood Narrative

177

1410

0.86

1.24

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

140

0.54

1.24

1.2

3.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

251

1950

0.88

1.24

1.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

251

1950

0.88

1.24

1.3

1.5

—

(3003577) Lead [Moles/volume] in Blood

2.03

1.23

1.2

1.1

0.11

0.10

umol/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

148

0.55

1.22

1.0

1.1

15.00

19.53

iu/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

199

0.62

1.21

4.8

7.1

—

(3014051) Protein [Presence] in Urine by Test strip

516

3227

1.09

1.21

2.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

265

1.34

1.20

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

1.19

0.0

1.1

—

8.22

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4597

32222

0.97

1.18

2.6

3.1

33.33

36.72

u/l

2.19

4248

30111

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

455

3406

0.91

1.17

1.9

2.2

116.05

105.17

ug/min

0.17

226

1917

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14880

102525

0.97

1.17

5.0

5.7

2.44

2.50

mmol/l

15.38

12995

91079

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

130

744

1.20

1.16

2.2

2.0

2.18

2.48

u/field

0.23

489

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

1.16

0.0

1.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2711

19180

0.96

1.16

2.1

2.6

20.48

21.04

1.22

2020

16222

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

850

5436

1.07

1.15

1.2

1.3

51.02

62.86

au/ml

0.70

288

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.43

1.15

1.4

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

132

1069

0.84

1.15

1.7

1.8

175.86

188.70

pmol/l

1.02

113

969

(3017569) Oxygen content in Arterial blood

754

0.81

1.13

2.2

2.1

—

(3016879) Cocaine [Presence] in Urine

322

1.30

1.12

1.7

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

234

1811

0.88

1.12

1.3

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1029

7450

0.94

1.12

1.4

1.6

1.59

1.57

g/l

0.35

814

6335

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

832

6065

0.93

1.12

1.9

2.3

3.79

3.72

g/l

0.54

658

5369

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

135

1.47

1.12

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.62

1.11

1.1

1.7

2.29

0.97

mmol/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3669

25780

0.97

1.09

3.2

3.5

0.82

0.85

ug/l

0.50

2647

19230

(3043410) Blood group antigens tested for on Red Blood Cells

369

0.74

1.09

1.8

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

783

5711

0.93

1.08

1.9

2.3

10.33

10.27

g/l

0.13

603

4964

(3038177) Helicobacter pylori Ab [Presence] in Serum

148

1179

0.86

1.08

1.5

1.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

175

0.62

1.06

1.0

1.5

—

46.75

—

(3020491) Glucose [Moles/volume] in Blood

143

834

1.17

1.06

1.8

2.2

7.47

7.17

mmol/l

0.49

104

563

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

104

0.53

1.06

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

836

6076

0.94

1.04

1.9

2.3

—

(3036180) Methadone [Presence] in Urine

1.57

1.04

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.45

1.03

1.6

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.45

1.03

1.6

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.45

1.03

1.6

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.45

1.03

1.6

1.5

—

(4146454) Self-monitoring of blood glucose

213

1647

0.88

1.03

2.5

2.7

—

(3035933) Granulocytes/100 leukocytes in Blood

131

0.57

1.02

1.5

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

838

6081

0.94

1.01

1.9

2.3

7.57

7.52

g/l

0.33

660

5380

(3018291) Platelet Ab [Presence] in Serum

0.00

1.00

0.0

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

164

0.62

1.00

2.2

1.7

53.00

1710.76

e6/l

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

141

826

1.17

1.00

1.3

1.6

—

2.92

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

213

0.67

1.00

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

152

1199

0.87

0.99

1.2

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2149

14163

1.04

0.99

1.7

1.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1801

12799

0.96

0.98

2.1

2.6

65.61

65.91

g/l

0.88

1483

11430

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.97

0.0

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.97

0.0

8.3

—

46.27

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

162

0.63

0.96

1.1

1.3

—

(3017732) Neutrophils [#/volume] in Blood

1089

7071

1.06

0.95

3.4

3.3

5.48

5.71

e9/l

0.19

749

5071

(3000012) Reticulocyte production index

320

2404

0.91

0.94

1.8

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

497

0.80

0.94

1.0

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

289

0.73

0.93

1.5

1.6

83.19

116.31

ug/l

1.32

242

(3051651) Icteric interference index of Serum or Plasma

101

816

0.84

0.91

3.1

4.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

232

0.71

0.90

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

232

0.71

0.90

1.2

1.1

71.86

82.24

—

123

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

380

0.77

0.90

1.1

1.06

1.11

ratio

0.87

115

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.95

0.90

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

163

1268

0.88

0.90

1.1

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

340

1.25

0.89

1.7

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.65

0.89

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

113

659

1.17

0.88

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.68

0.88

1.2

1.0

164.57

174.96

pmol/l

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.05

0.87

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

116

0.59

0.87

1.5

1.2

—

743.82

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

507

3718

0.93

0.87

1.3

1.4

265.14

259.32

ug/g

0.28

282

2311

(3001019) Free T4 and TSH panel - Serum or Plasma

143

1117

0.87

0.85

1.5

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

132

0.62

0.85

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

468

1.20

0.83

1.8

13.35

14.34

nmol/l

0.58

426

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.76

0.83

1.1

—

(3044927) Protein electrophoresis panel - Urine

273

1696

1.10

0.82

1.2

—

(3013512) EKG study

5755

38647

1.02

0.82

4.6

4.7

—

(3027008) Opiates [Presence] in Urine

345

1.23

0.81

1.7

1.3

—

(3028300) Cannabinoids [Presence] in Urine

345

1.23

0.81

1.7

1.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.80

0.0

2.3

—

2.31

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.56

0.80

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

544

3963

0.94

0.79

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

248

1.27

0.79

1.2

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

241

0.74

0.79

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

544

0.83

0.78

1.3

778.29

227.43

ug/l

0.55

295

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

355

2625

0.92

0.78

1.5

1.6

—

(3004451) EKG impression Narrative

102

807

0.86

0.75

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.14

0.75

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

361

0.79

0.74

2.4

2.0

14.73

46.59

u/l

3.49

339

(3010421) pH of Blood

575

3701

1.06

0.73

3.1

4.3

7.42

0.65

516

3374

(40758558) Short blood count panel - Blood

4051

28238

0.98

0.73

5.1

6.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

253

0.76

0.73

1.1

—

(40762814) Titanium [Mass/volume] in Blood

299

0.78

0.73

2.1

2.2

2.89

3.38

ug/l

0.86

115

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

118

0.64

0.72

1.1

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

538

3459

1.06

0.72

3.5

3.8

8.01

7.69

mmol/l

1.46

527

3390

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

229

0.75

0.72

1.2

78.63

79.69

—

124

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

419

0.81

0.71

1.0

1.1

6.64

12.61

iu/ml

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

228

1.26

0.70

1.2

1.1

1661.38

1707.34

miu/ml

0.09

228

(3017315) Amylase [Enzymatic activity/volume] in Urine

596

0.85

0.70

1.1

1.2

201.60

303.21

u/l

1.01

550

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1236

8772

0.96

0.69

5.4

7.6

0.71

0.66

3.73

1226

8705

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

126

1.36

0.69

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

253

1.24

0.69

1.1

—

(3028433) Virus identified in Specimen by Culture

387

0.81

0.69

1.1

—

(3003129) Base excess in Capillary blood by calculation

387

0.81

0.69

1.3

1.9

1.00

0.67

mmol/l

0.24

367

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

827

5392

1.05

0.68

3.2

4.3

25.06

24.88

mmol/l

0.91

705

4926

(3008037) Lactate [Moles/volume] in Venous blood

562

3628

1.06

0.67

3.4

3.7

1.66

1.64

mmol/l

0.23

549

3553

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

460

0.83

0.67

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

460

0.83

0.67

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

489

0.84

0.66

1.2

39.67

40.27

g/l

0.15

238

(4212803) Bone marrow aspirate examination

155

0.71

0.65

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.62

0.65

1.6

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.62

0.65

1.0

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

165

1015

1.11

0.65

1.3

270.87

399.40

titre

0.51

100

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

956

6265

1.04

0.65

1.7

1.9

2.73

2.23

ug/l

0.41

745

5451

(3000330) Specific gravity of Urine by Test strip

1094

7191

1.04

0.64

4.3

4.1

—

(3019977) pH of Arterial blood

141

860

1.12

0.64

2.0

2.4

7.43

7.42

0.35

358

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.58

0.63

2.5

1.5

291.00

201.81

ng/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

103

801

0.88

0.63

1.1

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.55

0.63

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

344

0.81

0.62

1.5

1.4

0.14

0.17

nmol/l

0.40

244

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

784

5600

0.95

0.62

2.0

2.3

2.96

3.00

g/l

0.45

608

4900

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

366

0.82

0.61

1.2

1.5

16.71

972.12

u/l

0.74

129

(3000285) Sodium [Moles/volume] in Blood

196

1.26

0.61

1.4

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

160

988

1.11

0.60

1.4

1.3

28.00

66.14

titre

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1244

8795

0.96

0.60

5.4

7.5

1.44

1.32

3.64

1235

8723

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

175

0.74

0.59

1.1

1.2

18.73

17.71

u/l

0.11

122

(3028679) Herpes simplex virus Ab [Presence] in Serum

315

1.19

0.59

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

274

0.80

0.58

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

151

0.72

0.58

1.4

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

143

0.72

0.58

1.5

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

470

3391

0.95

0.56

2.3

2.9

7.59

7.78

kpa

1.69

459

3315

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

154

1159

0.91

0.56

1.3

1.5

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

157

0.74

0.55

1.1

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.50

0.54

1.3

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

172

0.75

0.54

1.2

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

536

0.87

0.53

1.1

3.0

60.92

73.37

mg/l

0.87

371

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

515

3697

0.95

0.53

1.1

1.70

5.75

u/ml

0.43

(3024263) Appearance of Synovial fluid

106

646

1.12

0.53

1.2

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

485

3149

1.05

0.52

2.2

2.6

16.18

15.69

1.80

232

1696

(3009343) pH of Capillary blood

1349

8949

1.03

0.52

2.8

3.8

7.42

0.13

175

1185

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

239

0.80

0.52

1.8

1.6

9.80

9.68

ug/l

0.06

239

(3041354) Potassium [Moles/volume] in Venous blood

344

2213

1.06

0.51

2.5

2.6

4.11

mmol/l

0.03

338

2196

(3035285) Chloride [Moles/volume] in Venous blood

344

2213

1.06

0.51

2.5

2.6

106.18

105.55

mmol/l

1.44

338

2195

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

714

5080

0.96

0.51

1.9

2.5

1.23

1.10

g/l

0.32

531

4256

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.64

0.49

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

170

1263

0.92

0.49

1.2

1.4

152336.33

180660.41

e6/l

0.17

105

873

(3015183) Erythrocyte sedimentation rate

192

0.78

0.49

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

698

0.89

0.49

1.6

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

252

0.81

0.49

1.2

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1363

9056

1.03

0.49

2.9

3.8

5.18

5.15

kpa

0.64

1222

8558

(3025018) Bordetella pertussis Ab [Titer] in Serum

363

0.85

0.48

1.2

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

289

0.83

0.48

1.1

251.73

275.14

pmol/l

0.21

200

(3009015) Lactate [Moles/volume] in Synovial fluid

161

0.76

0.48

1.1

1.2

7.15

6.78

mmol/l

—

(3006576) Bicarbonate [Moles/volume] in Blood

494

0.87

0.48

3.4

6.6

24.72

24.93

mmol/l

0.22

445

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.49

0.48

1.1

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1302

8652

1.03

0.47

2.9

3.8

1.90

1.98

mmol/l

0.38

917

6465

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

259

1888

0.94

0.47

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.61

0.47

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

339

2190

1.06

0.46

2.5

2.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

578

0.89

0.45

1.3

3.70

3.33

mmol/l

0.41

532

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3414

23693

0.98

0.45

1.6

1.7

1.66

1.55

mg/l

0.81

2640

18611

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.35

0.44

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.48

0.44

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

320

1.15

0.43

2.6

2.5

7.25

7.82

mmol/l

0.70

208

(3030313) Adrenal Ab [Titer] in Serum

1.44

0.43

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2747

19092

0.98

0.43

1.2

1.84

1.71

u/ml

0.18

608

4415

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

180

0.80

0.42

1.0

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.42

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

186

1183

1.07

0.42

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.42

0.0

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

0.42

0.0

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

162

1194

0.93

0.41

2.7

3.1

30.37

40.24

mg/l

0.53

119

878

(3052851) Hemolysis interference index of Serum or Plasma

591

4196

0.96

0.41

3.4

3.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

131

822

1.09

0.41

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.40

0.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

145

915

1.08

0.40

1.2

1.16

1.47

nmol/l

4.99

132

824

(3036525) Urea [Moles/time] in 24 hour Urine

0.66

0.40

2.1

3.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

744

0.91

0.40

1.1

3.75

5.33

u/ml

0.39

141

(3016244) Insulin [Units/volume] in Serum or Plasma

260

0.84

0.40

1.5

2.1

18.62

18.90

mu/l

0.02

236

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

672

0.90

0.39

1.2

9.75

9.55

mmol/l

0.16

636

(3022948) Iron [Moles/volume] in Serum or Plasma

3209

21607

1.02

0.39

2.1

2.6

11.30

11.78

umol/l

3.39

2794

19884

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

—

(3027944) Amphetamines [Presence] in Urine

330

1.14

0.38

1.7

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

281

0.85

0.38

1.3

1.1

0.61

0.65

umol/24h

0.19

124

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1529

10676

0.98

0.38

2.1

2.4

36.40

47.86

u/l

0.83

1240

9082

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.71

0.38

1.3

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

497

0.89

0.37

2.8

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

240

1549

1.06

0.37

1.5

1.4

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.73

0.36

2.1

1.8

7.00

16.40

—

(3050794) Legionella sp Ab [Presence] in Serum

0.73

0.36

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

146

0.80

0.36

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.39

0.35

1.4

1.3

—

(3048879) Bone marrow aspiration report

488

0.90

0.35

1.1

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

411

2696

1.04

0.34

1.2

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

197

0.83

0.34

1.0

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

226

0.85

0.34

1.4

82.17

74.37

0.64

191

(3024928) Oxygen saturation in Venous blood

425

2794

1.04

0.33

1.7

2.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

181

0.83

0.33

2.2

2.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

319

0.88

0.32

1.1

1.2

1.48

1.49

mmol/l

0.01

200

(3035320) C reactive protein [Mass/volume] in Body fluid

130

828

1.07

0.31

2.7

2.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

128

0.80

0.31

1.7

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

214

1387

1.05

0.31

2.8

—

(3017704) Immunofixation for Urine

136

870

1.07

0.30

1.3

1.5

—

(3012501) Base excess in Blood by calculation

493

3260

1.03

0.29

3.3

4.4

2.32

2.77

mmol/l

3.08

336

2261

(3021901) Oxygen saturation in Capillary blood

414

2930

0.96

0.29

2.3

2.9

—

(3013290) Carbon dioxide [Partial pressure] in Blood

493

3262

1.03

0.29

3.3

4.4

4.96

5.00

kpa

0.60

477

3173

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2917

20173

0.99

0.29

2.0

2.6

2.21

2.25

g/l

3.61

2537

18484

(40757494) Bilirubin.total [Moles/volume] in Blood

111

707

1.07

0.28

1.8

2.1

16.02

28.25

umol/l

1.00

(3006462) Nitrate [Presence] in Urine

629

0.92

0.28

4.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.74

0.28

1.4

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

257

0.88

0.27

1.3

1.2

42.25

78.37

mu/l

1.58

184

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

308

2188

0.96

0.27

1.4

1.6

3.28

4.71

iu/l

2.33

628

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.78

0.27

1.2

1.5

0.52

0.85

umol/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.70

0.26

1.2

1.1

178.40

290.72

nmol/l

—

(3020650) Glucose [Presence] in Urine

198

1.14

0.26

2.2

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

101

644

1.07

0.26

2.1

1.7

92.17

97.87

umol/l

0.59

101

644

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

302

1.11

0.26

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.21

0.25

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1722

11595

1.02

0.25

1.7

2.1

0.20

g/l

0.15

1504

10685

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

124

0.83

0.25

1.0

1.1

1.79

1.69

umol/24h

0.27

124

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.72

0.24

8.5

8.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

101

646

1.07

0.24

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

148

1.15

0.23

3.8

5.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

233

1658

0.96

0.23

1.2

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

439

0.92

0.23

1.3

1.4

18.21

20.35

0.27

366

(40762887) Creatinine [Moles/volume] in Blood

1.31

0.23

1.2

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

187

1.13

0.23

1.2

1.3

81.30

106.17

ug/l

0.61

118

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.75

0.23

1.0

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

245

0.89

0.22

1.1

1.3

0.64

1.46

mmol/l

1.16

156

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.22

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.22

0.0

1.3

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.22

0.0

1.0

—

19.63

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.22

0.0

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.4

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.22

0.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.3

—

25.12

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

209

0.88

0.22

1.0

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

252

0.89

0.22

1.3

1.4

22.10

21.10

0.06

198

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

332

1.09

0.22

1.3

1.2

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

6.4

—

8.00

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.7

—

15.00

—

(3049717) Cytology report of Urine Cyto stain

960

6447

1.02

0.21

2.7

2.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

823

5519

1.02

0.21

2.6

3.2

4.30

pmol/l

0.01

690

4728

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.28

0.21

1.5

508.77

465.82

nmol/l

—

(3027315) Oxygen [Partial pressure] in Blood

492

3280

1.03

0.20

3.3

4.4

8.18

8.34

kpa

1.15

475

3191

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.80

0.20

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.80

0.20

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.83

0.20

1.1

9.08

11.41

u/l

0.33

(3021387) Prolactin [Units/volume] in Serum or Plasma

147

1051

0.96

0.20

2.2

1.8

293.24

307.90

mu/l

0.30

132

968

(3024522) Salmonella sp identified in Specimen by Organism specific culture

236

1670

0.97

0.20

1.2

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.81

0.19

3.3

4.2

—

(3026470) Cobalt [Mass/volume] in Blood

145

1036

0.96

0.19

1.8

1.9

2.89

4.07

ug/l

1.89

133

946

(3035611) Eosinophils/100 leukocytes in Synovial fluid

106

1.16

0.18

1.5

1.8

1.24

0.80

0.24

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

156

0.88

0.18

1.4

1.1

93.60

76.68

—

(3005011) Chlamydia sp Ab [Titer] in Serum

100

1.16

0.18

2.1

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

126

1.14

0.18

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1579

10666

1.01

0.17

2.1

2.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

556

3876

0.98

0.17

2.4

3.1

24.94

mmol/l

0.00

540

3797

(3032868) Hemoglobin electrophoresis panel in Blood

0.74

0.17

1.8

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

264

1.09

0.17

1.4

1.5

105.20

128.60

ng/l

0.87

264

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.71

0.17

1.8

2.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.76

0.16

1.2

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

225

0.91

0.16

1.2

1.3

36.94

350.09

u/l

0.86

159

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.15

0.15

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.15

0.15

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.15

0.15

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

387

2701

0.98

0.15

1.6

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

526

0.95

0.15

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

103

0.86

0.15

1.5

2.6

5.40

17.51

ug/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

291

1940

1.03

0.14

2.1

2.2

31.17

27.53

mg/l

0.37

481

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

115

1.13

0.14

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

313

1.07

0.14

1.3

28.97

32.33

0.25

204

(3051101) Glucose [Moles/volume] in Cord blood

301

0.93

0.14

4.6

6.1

—

(3001729) Color of Synovial fluid

122

1.12

0.14

1.5

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

674

4674

0.98

0.14

1.9

2.3

36.65

36.95

g/l

0.59

493

3958

(3014891) Appearance of Pleural fluid

274

1.07

0.14

1.3

—

(3022313) Gas panel - Capillary blood

926

6405

0.99

0.13

3.0

4.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

300

0.93

0.13

1.1

1.40

15.18

u/ml

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

102

0.87

0.13

1.9

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

106

752

0.96

0.12

1.5

1.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.15

0.12

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

310

1.06

0.11

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

1.14

0.11

1.0

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

0.86

0.11

1.3

0.40

0.64

ml/s/173m2

—

(3045424) Erythrocytes [Presence] in Urine

277

1930

0.98

0.11

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.88

0.10

1.1

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

218

1522

0.98

0.10

3.2

3.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

231

1.06

0.10

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.14

0.10

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

112

1.10

0.09

1.2

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

236

1643

0.98

0.09

1.2

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

344

0.95

0.09

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

155

0.93

0.08

1.2

1.1

95.00

72.24

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.81

0.08

1.6

1.5

—

(3044941) Cell count panel - Synovial fluid

289

2005

0.98

0.08

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

185

1241

1.02

0.07

1.3

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

105

0.91

0.07

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

237

1644

0.98

0.07

1.2

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

515

3485

1.01

0.07

1.1

270.71

198.49

titre

0.24

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1126

7741

0.99

0.07

2.5

2.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.87

0.07

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

356

1.04

0.06

1.1

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

237

1641

0.99

0.06

1.2

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.91

0.06

1.1

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.90

0.06

1.1

—

(3019174) dRVVT (LA screen)

1.11

0.05

1.0

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

166

0.95

0.05

1.3

1.7

41.78

47.59

umol/l

0.57

166

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

358

1.03

0.05

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

631

4284

1.01

0.05

5.2

4.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

559

0.98

0.05

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1089

7407

1.00

0.05

6.1

8.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

184

1241

1.01

0.05

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

276

0.97

0.04

1.2

1.3

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.08

0.04

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

513

3483

1.01

0.04

1.3

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

246

1696

0.99

0.04

1.2

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

116

0.94

0.03

1.4

1.5

—

(1616796) Gas panel - Central venous blood

479

3291

0.99

0.03

2.8

3.8

—

(36660697) Celiac disease serology panel - Serum

1020

6990

1.00

0.03

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

253

1.03

0.02

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

390

1.02

0.02

1.5

1.7

6.69

5.16

nmol/l

0.18

340

(3034274) Bile acid [Moles/volume] in Serum --fasting

430

0.99

0.01

1.4

1.3

9.36

14.31

umol/l

0.53

299

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

547

1.01

0.01

1.1

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

329

1.02

0.01

1.5

1.6

0.35

0.39

ug/l

0.25

190

(40761539) Cells [Type] in Urine sediment by Light microscopy

368

0.98

0.01

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

152

1.03

0.01

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.94

0.01

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

160

1.02

0.00

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.04

0.00

1.0

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.96

0.00

1.2

1.3

0.08

0.06

g/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.96

0.00

1.2

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

590

1.00

0.00

1.0

1.1

5.32

8.77

nmol/l

0.38

133

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

317

0.99

0.00

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

159

0.99

0.00

1.1

1.3

3285.41

187.19

ng/l

0.51

101

(3025577) Chromium [Mass/volume] in Blood

146

999

1.00

0.00

1.9

2.0

1.82

2.35

ug/l

1.90

120

828

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

435

1.01

0.00

1.7

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

553

1.00

0.00

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

144

1.00

0.00

2.2

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

106

1.03

0.00

1.1

—

(3037121) Protein [Mass/volume] in Urine

680

4646

1.00

0.00

2.4

2.9

0.32

0.31

g/l

0.11

226

1906

(3025549) Creatine [Moles/time] in 24 hour Urine

119

0.98

0.00

1.3

1.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

417

1.00

0.00

1.2

1.4

74.96

61.16

3.26

358

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.00

0.00

1.5

1.3

1.17

1.00

u/field

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.44

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.6

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.00

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.99

-0.00

1.0

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.98

-0.00

1.0

1.1

1.33

1.03

u/field

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.95

-0.00

1.2

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: G6_NEURODEGENERATIVE – Unspecific neurodegenerative disorder

GWS hits: 48

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Unspecific neurodegenerative disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Unspecific neurodegenerative disorder (G6_NEURODEGENERATIVE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints